<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">CMAJ</journal-id><journal-id journal-id-type="iso-abbrev">CMAJ</journal-id><journal-id journal-id-type="pmc-domain-id">77</journal-id><journal-id journal-id-type="pmc-domain">cmaj</journal-id><journal-id journal-id-type="publisher-id">9711805</journal-id><journal-title-group><journal-title>CMAJ : Canadian Medical Association Journal</journal-title></journal-title-group><issn pub-type="ppub">0820-3946</issn><issn pub-type="epub">1488-2329</issn><publisher><publisher-name>Canadian Medical Association</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11057880</article-id><article-id pub-id-type="pmcid-ver">PMC11057880.1</article-id><article-id pub-id-type="pmcaid">11057880</article-id><article-id pub-id-type="pmcaiid">11057880</article-id><article-id pub-id-type="pmid">38684285</article-id><article-id pub-id-type="doi">10.1503/cmaj.231419</article-id><article-id pub-id-type="publisher-id">196e547</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research</subject><subj-group><subject>Access to Health Care</subject></subj-group></subj-group></article-categories><title-group><article-title>Association between opioid use disorder and palliative care: a cohort study using linked health administrative data in Ontario, Canada</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Lau</surname><given-names initials="J">Jenny</given-names></name><degrees>MD MSc</degrees></contrib><contrib contrib-type="author"><name name-style="western"><surname>Scott</surname><given-names initials="MM">Mary M.</given-names></name><degrees>MSc</degrees></contrib><contrib contrib-type="author"><name name-style="western"><surname>Everett</surname><given-names initials="K">Karl</given-names></name><degrees>MSc</degrees></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gomes</surname><given-names initials="T">Tara</given-names></name><degrees>PhD</degrees></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tanuseputro</surname><given-names initials="P">Peter</given-names></name><degrees>MD MHSc</degrees></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jennings</surname><given-names initials="S">Sheila</given-names></name><degrees>LLB PhD</degrees></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bagnarol</surname><given-names initials="R">Rebecca</given-names></name><degrees>MPH</degrees></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zimmermann</surname><given-names initials="C">Camilla</given-names></name><degrees>MD PhD</degrees></contrib><contrib contrib-type="author"><name name-style="western"><surname>Isenberg</surname><given-names initials="SR">Sarina R.</given-names></name><degrees>PhD</degrees></contrib><aff id="af1-196e547">Division of Palliative Care (Lau, Bagnarol, Zimmermann), Princess Margaret Cancer Centre, University Health Network; Division of Palliative Care (Lau), Department of Family and Community Medicine, University of Toronto, Toronto, Ont.; Ottawa Hospital Research Institute (Scott, Tanuseputro), Ottawa, Ont.; ICES Central (Everett, Gomes); Li Ka Shing Knowledge Institute (Gomes), Unity Health; Leslie Dan Faculty of Pharmacy (Gomes), University of Toronto, Toronto, Ont.; Bruy&#232;re Research Institute (Tanuseputro, Isenberg), Ottawa, Ont.; Moms Stop The Harm (Jennings); Division of Palliative Medicine (Zimmermann), Department of Medicine, University of Toronto, Toronto, Ont.; Division of Palliative Care (Isenberg), Department of Medicine, University of Ottawa, Ottawa, Ont.</aff></contrib-group><author-notes><corresp id="c1-196e547">Correspondence to: Jenny Lau, <email>Jenny.Lau@uhn.ca</email></corresp></author-notes><pub-date pub-type="ppub"><day>29</day><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>29</day><month>4</month><year>2024</year></pub-date><volume>196</volume><issue>16</issue><issue-id pub-id-type="pmc-issue-id">461301</issue-id><fpage>E547</fpage><lpage>E557</lpage><history><date date-type="accepted"><day>12</day><month>3</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>29</day><month>04</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>01</day><month>05</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-01-08 19:25:40.350"><day>08</day><month>01</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2024 CMA Impact Inc. or its licensors</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">https://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link></license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="196e547.pdf"/><abstract><sec><title>Background:</title><p>People with opioid use disorder (OUD) are at risk of premature death and can benefit from palliative care. We sought to compare palliative care provision for decedents with and without OUD.</p></sec><sec><title>Methods:</title><p>We conducted a cohort study using health administrative databases in Ontario, Canada, to identify people who died between July 1, 2015, and Dec. 31, 2021. The exposure was OUD, defined as having emergency department visits, hospital admissions, or pharmacologic treatments suggestive of OUD within 3 years of death. Our primary outcome was receipt of 1 or more palliative care services during the last 90 days before death. Secondary outcomes included setting, initiation, and intensity of palliative care. We conducted a secondary analysis excluding sudden deaths (e.g., opioid toxicity, injury).</p></sec><sec><title>Results:</title><p>Of 679 840 decedents, 11 200 (1.6%) had OUD. Compared with people without OUD, those with OUD died at a younger age and were more likely to live in neighbourhoods with high marginalization indices. We found people with OUD were less likely to receive palliative care at the end of their lives (adjusted relative risk [RR] 0.84, 95% confidence interval [CI] 0.82&#8211;0.86), but this difference did not exist after excluding people who died suddenly (adjusted RR 0.99, 95% CI 0.96&#8211;1.01). People with OUD were less likely to receive palliative care in clinics and their homes regardless of cause of death.</p></sec><sec><title>Interpretation:</title><p>Opioid use disorder can be a chronic, life-limiting illness, and people with OUD are less likely to receive palliative care in communities during the 90 days before death. Health care providers should receive training in palliative care and addiction medicine to support people with OUD.</p></sec></abstract><funding-group><award-group><funding-source id="CS1">Canadian Institutes of Health Research</funding-source><award-id award-type="contract" rid="CS1">RN467572 &#8212; 471128</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p>Between 1990 and 2016, the number of people with opioid use disorder (OUD) worldwide increased from 18.2 million to 26.8 million people.<xref rid="b1-196e547" ref-type="bibr">1</xref>,<xref rid="b2-196e547" ref-type="bibr">2</xref> As this population ages, more people with OUD will require access to palliative care at the end of their lives. In addition to the risk of dying from opioid poisoning, people with OUD who survive nonfatal opioid poisoning can have severe complications such as hypoxic brain injury, as well as serious infections from injecting opioids.<xref rid="b3-196e547" ref-type="bibr">3</xref>,<xref rid="b4-196e547" ref-type="bibr">4</xref> Socioeconomic inequities and comorbidities are also more prevalent among people with OUD, contributing further to premature death.<xref rid="b5-196e547" ref-type="bibr">5</xref>,<xref rid="b6-196e547" ref-type="bibr">6</xref> A Norwegian cohort study found that 45% of people with OUD died of chronic illnesses such as cancer, cardiovascular diseases, and liver diseases.<xref rid="b7-196e547" ref-type="bibr">7</xref></p><p>Palliative care improves quality of life for people with life-limiting illnesses through symptom management and psychosocial support.<xref rid="b8-196e547" ref-type="bibr">8</xref> National data indicate that 62%&#8211;89% of people in Canada who die can benefit from receiving palliative care,<xref rid="b9-196e547" ref-type="bibr">9</xref> but the number of people with OUD who receive palliative care at the end of their lives is unknown. As the drug toxicity crisis continues, there is an urgent need to understand and support this population. Therefore, we sought to compare palliative care provision at the end of life between people with and without OUD.</p><sec sec-type="methods"><title>Methods</title><sec sec-type="methods"><title>Study setting and design</title><p>All registered Ontario residents are provided publicly funded hospital and physician services. People are provided drug insurance coverage if they are older than 65 years; live in either a long-term care home, a home for special care, or a Community Home for Opportunity; are aged 24 years or younger and do not have a private drug insurance plan; receive professional home and community care services; receive benefits from Ontario Works or Ontario Disability Support Program; or are enrolled in the Trillium Drug Program.<xref rid="b10-196e547" ref-type="bibr">10</xref></p><p>We conducted a population-level retrospective cohort study of Ontario decedents, comparing palliative care provision for those with OUD with all other decedents.</p></sec><sec sec-type="methods"><title>Study population</title><p>We identified people between the ages of 18 and 104 years who died between July 1, 2015, and Dec. 31, 2021, in Ontario. We excluded people with missing or invalid data for sex or postal code, non-Ontario residents at the index date (90 d before date of death), those ineligible for public health insurance during the 3 years before the index date, and those whose date of last contact with the health care system was 5 years or more after the index date.</p></sec><sec><title>Exposure</title><p>We defined OUD as at least 1 emergency department visit or hospital admission associated with <italic toggle="yes">International Disease Classification, 10th Revision</italic> codes for OUD (F11.0&#8211;F11.9), or a prescription for opioid agonist treatment, within 3 years before the index date.<xref rid="b11-196e547" ref-type="bibr">11</xref>,<xref rid="b12-196e547" ref-type="bibr">12</xref> The definition of OUD was based on case-finding algorithms developed in British Columbia.<xref rid="b13-196e547" ref-type="bibr">13</xref>,<xref rid="b14-196e547" ref-type="bibr">14</xref> Appendix 1, available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="www.cmaj.ca/lookup/doi/10.1503/cmaj.231419/tab-related-content" ext-link-type="uri">www.cmaj.ca/lookup/doi/10.1503/cmaj.231419/tab-related-content</ext-link>, provides additional details about this definition of OUD and the results of sensitivity analyses we conducted, varying the definition.</p></sec><sec sec-type="methods"><title>Data sources</title><p>We used health administrative data sets linked by unique, encoded identifiers at ICES (Appendix 2, available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="www.cmaj.ca/lookup/doi/10.1503/cmaj.231419/tab-related-content" ext-link-type="uri">www.cmaj.ca/lookup/doi/10.1503/cmaj.231419/tab-related-content</ext-link>). The Registered Persons Database, the Ontario Marginalization Index, and the Immigration, Refugees and Citizenship Canada database were used to identify demographic, socioeconomic and immigration status, respectively. Hospital admissions, emergency department visits, mental health admissions, and prescriptions for opioid agonist treatment were identified using the Canadian Institute for Health Information&#8217;s Discharge Abstract Database, National Ambulatory Care Reporting System, Ontario Mental Health Reporting System, and Narcotic Monitoring System, respectively. The Ontario Health Insurance Plan (OHIP) database, Ontario HIV Database, and Ontario Drug Benefits database were used to determine the decedents&#8217; comorbidities, substance use history, and the diagnoses associated with palliative care assessments conducted by physicians. Cause of death was determined using the Ontario Vital Statistics Deaths Registry and the Drugand Drug/Alcohol-Related Death Database.</p></sec><sec sec-type="intro"><title>Cohort characteristics</title><p>We determined demographic characteristics at the index date and clinical characteristics during the 3 years before the index date, including 13 of the most common chronic conditions (Appendix 3, available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="www.cmaj.ca/lookup/doi/10.1503/cmaj.231419/tab-related-content" ext-link-type="uri">www.cmaj.ca/lookup/doi/10.1503/cmaj.231419/tab-related-content</ext-link>).<xref rid="b15-196e547" ref-type="bibr">15</xref>&#8211;<xref rid="b29-196e547" ref-type="bibr">29</xref> We used the Charlson Comorbidity Index as a composite measure of comorbidity. We also identified whether the decedents experienced serious infections associated with injection drug use (i.e., infective endocarditis, hepatitis C, and HIV),<xref rid="b30-196e547" ref-type="bibr">30</xref>,<xref rid="b31-196e547" ref-type="bibr">31</xref> and harms from benzodiazepine, stimulant, and alcohol use (Appendix 4, available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="www.cmaj.ca/lookup/doi/10.1503/cmaj.231419/tab-related-content" ext-link-type="uri">www.cmaj.ca/lookup/doi/10.1503/cmaj.231419/tab-related-content</ext-link>).<xref rid="b1-196e547" ref-type="bibr">1</xref></p></sec><sec><title>Outcomes</title><p>The primary outcome was receipt of 1 or more publicly funded palliative care services during the end-of-life period, which we defined as the last 90 days of life, when death is most predictable and palliative care is most often provided.<xref rid="b32-196e547" ref-type="bibr">32</xref> Secondary outcomes included palliative care setting, timing of initiation, and intensity. We classified setting as palliative care provided in clinics, homes (physician visits and OHIP funded non-physician home care), acute care hospitals (emergency department and inpatient units) and long-term care institutions (nursing homes and complex continuing care facilities) (Appendix 5, available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="www.cmaj.ca/lookup/doi/10.1503/cmaj.231419/tab-related-content" ext-link-type="uri">www.cmaj.ca/lookup/doi/10.1503/cmaj.231419/tab-related-content</ext-link>). For palliative care initiation, we looked back 365 days from time of death to identify the number of decedents who received their first palliative care service during end of life. We defined intensity as the number of days where palliative care was provided in any care setting during end of life. Among those who received palliative care, we identified the most common diagnoses associated with palliative care assessments conducted by physicians.</p></sec><sec sec-type="methods"><title>Statistical analysis</title><p>We matched people with OUD to those without OUD on age (&#177; 2 yr). We used absolute standardized differences to compare baseline characteristics between age-matched exposure groups, with differences greater than 0.1 representing meaningful imbalances. <xref rid="b33-196e547" ref-type="bibr">33</xref>&#8211;<xref rid="b37-196e547" ref-type="bibr">37</xref> We used modified Poisson regression models to estimate the relative risk (RR) of receiving palliative care, overall and by setting, among those with OUD compared with those without OUD after matching 1:4 on age (&#177; 2 yr).<xref rid="b38-196e547" ref-type="bibr">38</xref> We used zero-truncated negative binomial regression to calculate incidence rate ratios (IRRs) and to assess the association between OUD and palliative care intensity among those who received palliative care. We selected the following covariates based on clinical importance and adjusted for their potential confounding effects in our models: year at index date, sex, rurality, income quintile, dependency quintile, immigrant status, Charlson Comorbidity Index, presence of specific medical conditions (asthma, HIV, hepatitis C, infective endocarditis, cancer, congestive heart failure, chronic obstructive pulmonary disease [COPD], renal disease, and osteoarthritis) and history of harms from nonopioid substances (stimulants, benzodiazepines, alcohol). Using variance inflation factors, we did not identify any issues with multicollinearity between the covariates.</p><p>In a secondary analysis, we evaluated the impact of the COVID-19 pandemic by comparing the absolute and relative risks of receiving palliative care for decedents with and without OUD before the COVID-19 pandemic (July 1, 2015, to Dec. 31, 2019) and during the COVID-19 pandemic (Jan. 1, 2020, to Dec. 31, 2021).</p><p>We conducted another secondary analysis excluding decedents who had end-of-life illness trajectories associated with sudden death, identified using cause of death from the Ontario Vital Statistics &#8212; Deaths Registry (data available until December 2018) and established algorithms.<xref rid="b32-196e547" ref-type="bibr">32</xref> We defined sudden deaths as those that progressed &#8220;from normal function to death with little forewarning.&#8221; <xref rid="b39-196e547" ref-type="bibr">39</xref> We then compared palliative care provision at the end of life between age-matched people with and without OUD. We conducted this secondary analysis because palliative care provision may not be feasible or indicated for people who die from sudden causes like opioid toxicity or injury.</p></sec><sec><title>Ethics approval</title><p>This study did not require ethics approval. Use of data was authorized under section 45 of Ontario&#8217;s <italic toggle="yes">Personal Health Information Protection Act</italic>.</p></sec></sec><sec sec-type="results"><title>Results</title><p>During the study period, 679 840 adults died, including 11 200 (1.6%) with a history of OUD (<xref rid="f1-196e547" ref-type="fig">Figure 1</xref>). Among people with OUD, 5449 (48.7%) were only prescribed opioid agonist treatment for OUD; 3227 (28.8%) had OUD-related emergency department visits or hospital admissions; and 2524 (22.5%) had both opioid agonist treatment for OUD and OUD-related hospital admissions or emergency department visits. Of the 11 200 people with OUD, we matched 11 096 to at least 1 person without OUD (99.1%) on age. Of the 11 096 people with OUD, 9332 (84.1%) were matched with 4 people without OUD.</p><fig position="float" id="f1-196e547" orientation="portrait"><label>Figure 1:</label><caption><p>Study flowchart. Note: DOLC = date of last contact, OHIP = Ontario Health Insurance Plan.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="196e547f1.jpg"/></fig><sec sec-type="intro"><title>Demographics and clinical characteristics</title><p>Among all decedents, the mean age at death was 77.0 (standard deviation [SD] 15.1) years and 49% were female. People with OUD died at a much younger age than those without OUD (49.8 yr v. 77.5 yr, standardized difference 1.75). After matching for age, the baseline characteristics and medical histories of people with OUD differed from those who did not have OUD in several ways (<xref rid="t1-196e547" ref-type="table">Table 1</xref> and <xref rid="t2-196e547" ref-type="table">Table 2</xref>); people with OUD were more likely to live in neighbourhoods with the lowest income (37.9% v. 25.2%; standardized difference 0.28), highest material deprivation (39.5% v. 27.5%, standardized difference 0.26), and highest household and dwellings marginalization (42.8% v. 29.4%, standardized difference 0.28).</p><table-wrap position="float" id="t1-196e547" orientation="portrait"><label>Table 1:</label><caption><p>Baseline characteristics of decedent cohort, comparing those with a history of opioid use disorder (OUD) to those without OUD</p></caption><table frame="box" rules="rows"><thead><tr><th valign="bottom" rowspan="2" align="left" colspan="1">Characteristic</th><th colspan="8" valign="bottom" align="center" rowspan="1">No. (%) of decedents<xref rid="tfn1-196e547" ref-type="table-fn">*</xref></th><th valign="bottom" rowspan="2" align="center" colspan="1">Std Diff<xref rid="tfn3-196e547" ref-type="table-fn">&#8225;</xref></th></tr><tr><th valign="bottom" align="center" rowspan="1" colspan="1">Total<break/><italic toggle="yes">n</italic> = 679 840</th><th valign="bottom" align="center" rowspan="1" colspan="1">No OUD, total<break/><italic toggle="yes">n</italic> = 668 640</th><th valign="bottom" align="center" rowspan="1" colspan="1">OUD, total<break/><italic toggle="yes">n</italic> = 11 200</th><th valign="bottom" align="center" rowspan="1" colspan="1">OUD, hospital admissions or ED visits only<break/><italic toggle="yes">n</italic> = 3227</th><th valign="bottom" align="center" rowspan="1" colspan="1">OUD, OAT only<break/><italic toggle="yes">n</italic> = 5449</th><th valign="bottom" align="center" rowspan="1" colspan="1">OUD, hospital admissions or ED visits and OAT<break/><italic toggle="yes">n</italic> = 2524</th><th valign="bottom" align="center" rowspan="1" colspan="1">No OUD, age-matched<xref rid="tfn2-196e547" ref-type="table-fn">&#8224;</xref><break/><italic toggle="yes">n</italic> = 41 325</th><th valign="bottom" align="center" rowspan="1" colspan="1">OUD age-matched<xref rid="tfn2-196e547" ref-type="table-fn">&#8224;</xref><break/><italic toggle="yes">n</italic> = 11 096</th></tr></thead><tbody><tr><td colspan="10" valign="top" align="left" rowspan="1">Sex</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Female</td><td valign="top" align="center" rowspan="1" colspan="1">333 133 (49.0)</td><td valign="top" align="center" rowspan="1" colspan="1">329 138 (49.2)</td><td valign="top" align="center" rowspan="1" colspan="1">3995 (35.7)</td><td valign="top" align="center" rowspan="1" colspan="1">1453 (45.0)</td><td valign="top" align="center" rowspan="1" colspan="1">1666 (30.6)</td><td valign="top" align="center" rowspan="1" colspan="1">876 (34.7)</td><td valign="top" align="center" rowspan="1" colspan="1">16 215 (39.2)</td><td valign="top" align="center" rowspan="1" colspan="1">3957 (35.7)</td><td valign="top" align="center" rowspan="1" colspan="1">0.07</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Male</td><td valign="top" align="center" rowspan="1" colspan="1">346 707 (51.0)</td><td valign="top" align="center" rowspan="1" colspan="1">339 502 (50.8)</td><td valign="top" align="center" rowspan="1" colspan="1">7205 (64.3)</td><td valign="top" align="center" rowspan="1" colspan="1">1774 (55.0)</td><td valign="top" align="center" rowspan="1" colspan="1">3783 (69.4)</td><td valign="top" align="center" rowspan="1" colspan="1">1648 (65.3)</td><td valign="top" align="center" rowspan="1" colspan="1">25 110 (60.8)</td><td valign="top" align="center" rowspan="1" colspan="1">7139 (64.3)</td><td valign="top" align="center" rowspan="1" colspan="1">0.07</td></tr><tr><td colspan="10" valign="top" align="left" rowspan="1">Age, yr</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;18&#8211;44</td><td valign="top" align="center" rowspan="1" colspan="1">25 595 (3.8)</td><td valign="top" align="center" rowspan="1" colspan="1">20 978 (3.1)</td><td valign="top" align="center" rowspan="1" colspan="1">4617 (41.2)</td><td valign="top" align="center" rowspan="1" colspan="1">762&#8211;766<xref rid="tfn4-196e547" ref-type="table-fn">&#167;</xref></td><td valign="top" align="center" rowspan="1" colspan="1">2400 (44.0)</td><td valign="top" align="center" rowspan="1" colspan="1">1451&#8211;1455<xref rid="tfn4-196e547" ref-type="table-fn">&#167;</xref></td><td valign="top" align="center" rowspan="1" colspan="1">14 917 (36.1)</td><td valign="top" align="center" rowspan="1" colspan="1">4513 (41.2)</td><td valign="top" align="center" rowspan="1" colspan="1">0.09</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;45&#8211;54</td><td valign="top" align="center" rowspan="1" colspan="1">29 758 (4.4)</td><td valign="top" align="center" rowspan="1" colspan="1">27 557 (4.1)</td><td valign="top" align="center" rowspan="1" colspan="1">2201 (19.7)</td><td valign="top" align="center" rowspan="1" colspan="1">444 (13.8)</td><td valign="top" align="center" rowspan="1" colspan="1">1268 (23.3)</td><td valign="top" align="center" rowspan="1" colspan="1">489 (19.4)</td><td valign="top" align="center" rowspan="1" colspan="1">8656 (20.9)</td><td valign="top" align="center" rowspan="1" colspan="1">2201 (19.7)</td><td valign="top" align="center" rowspan="1" colspan="1">0.03</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;55&#8211;64</td><td valign="top" align="center" rowspan="1" colspan="1">73 187 (10.8)</td><td valign="top" align="center" rowspan="1" colspan="1">70 866 (10.6)</td><td valign="top" align="center" rowspan="1" colspan="1">2321 (20.7)</td><td valign="top" align="center" rowspan="1" colspan="1">678 (21.0)</td><td valign="top" align="center" rowspan="1" colspan="1">1214 (22.3)</td><td valign="top" align="center" rowspan="1" colspan="1">429 (17.0)</td><td valign="top" align="center" rowspan="1" colspan="1">9369 (22.7)</td><td valign="top" align="center" rowspan="1" colspan="1">2321 (20.7)</td><td valign="top" align="center" rowspan="1" colspan="1">0.04</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;65&#8211;74</td><td valign="top" align="center" rowspan="1" colspan="1">121 294 (17.8)</td><td valign="top" align="center" rowspan="1" colspan="1">120 186 (18.0)</td><td valign="top" align="center" rowspan="1" colspan="1">1108 (9.9)</td><td valign="top" align="center" rowspan="1" colspan="1">552 (17.1)</td><td valign="top" align="center" rowspan="1" colspan="1">430 (7.9)</td><td valign="top" align="center" rowspan="1" colspan="1">126 (5.0)</td><td valign="top" align="center" rowspan="1" colspan="1">4525 (10.9)</td><td valign="top" align="center" rowspan="1" colspan="1">1108 (9.9)</td><td valign="top" align="center" rowspan="1" colspan="1">0.03</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;75&#8211;84</td><td valign="top" align="center" rowspan="1" colspan="1">173 942 (25.6)</td><td valign="top" align="center" rowspan="1" colspan="1">173 365 (25.9)</td><td valign="top" align="center" rowspan="1" colspan="1">577 (5.2)</td><td valign="top" align="center" rowspan="1" colspan="1">442 (13.7)</td><td valign="top" align="center" rowspan="1" colspan="1">111 (2.0)</td><td valign="top" align="center" rowspan="1" colspan="1">24 (1.0)</td><td valign="top" align="center" rowspan="1" colspan="1">2288 (5.5)</td><td valign="top" align="center" rowspan="1" colspan="1">577 (5.2)</td><td valign="top" align="center" rowspan="1" colspan="1">0.02</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;&#8805; 85</td><td valign="top" align="center" rowspan="1" colspan="1">256 064 (37.7)</td><td valign="top" align="center" rowspan="1" colspan="1">255 688 (38.2)</td><td valign="top" align="center" rowspan="1" colspan="1">376 (3.4)</td><td valign="top" align="center" rowspan="1" colspan="1">345&#8211;349<xref rid="tfn4-196e547" ref-type="table-fn">&#167;</xref></td><td valign="top" align="center" rowspan="1" colspan="1">26 (0.5)</td><td valign="top" align="center" rowspan="1" colspan="1">1&#8211;5<xref rid="tfn4-196e547" ref-type="table-fn">&#167;</xref></td><td valign="top" align="center" rowspan="1" colspan="1">1570 (3.8)</td><td valign="top" align="center" rowspan="1" colspan="1">376 (3.4)</td><td valign="top" align="center" rowspan="1" colspan="1">0.02</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Age, yr, mean &#177; SD</td><td valign="top" align="center" rowspan="1" colspan="1">77.0 &#177; 15.1</td><td valign="top" align="center" rowspan="1" colspan="1">77.5 &#177; 14.7</td><td valign="top" align="center" rowspan="1" colspan="1">49.8 &#177; 16.8</td><td valign="top" align="center" rowspan="1" colspan="1">59.6 &#177; 19.1</td><td valign="top" align="center" rowspan="1" colspan="1">47.2 &#177; 13.9</td><td valign="top" align="center" rowspan="1" colspan="1">42.9 &#177; 13.6</td><td valign="top" align="center" rowspan="1" colspan="1">51.4 &#177; 16.7</td><td valign="top" align="center" rowspan="1" colspan="1">50.0 &#177; 16.8</td><td valign="top" align="center" rowspan="1" colspan="1">0.08</td></tr><tr><td colspan="10" valign="top" align="left" rowspan="1">Income quintile</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Q1 (lowest)</td><td valign="top" align="center" rowspan="1" colspan="1">157 655 (23.2)</td><td valign="top" align="center" rowspan="1" colspan="1">153 422 (22.9)</td><td valign="top" align="center" rowspan="1" colspan="1">4233 (37.8)</td><td valign="top" align="center" rowspan="1" colspan="1">1074 (33.3)</td><td valign="top" align="center" rowspan="1" colspan="1">2145 (39.4)</td><td valign="top" align="center" rowspan="1" colspan="1">1014 (40.2)</td><td valign="top" align="center" rowspan="1" colspan="1">10 398 (25.2)</td><td valign="top" align="center" rowspan="1" colspan="1">4201 (37.9)</td><td valign="top" align="center" rowspan="1" colspan="1">0.28</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Q2</td><td valign="top" align="center" rowspan="1" colspan="1">130 599 (19.2)</td><td valign="top" align="center" rowspan="1" colspan="1">128 479 (19.2)</td><td valign="top" align="center" rowspan="1" colspan="1">2120 (18.9)</td><td valign="top" align="center" rowspan="1" colspan="1">593 (18.4)</td><td valign="top" align="center" rowspan="1" colspan="1">1069 (19.6)</td><td valign="top" align="center" rowspan="1" colspan="1">458 (18.1)</td><td valign="top" align="center" rowspan="1" colspan="1">7853 (19.0)</td><td valign="top" align="center" rowspan="1" colspan="1">2096 (18.9)</td><td valign="top" align="center" rowspan="1" colspan="1">0.003</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Q3</td><td valign="top" align="center" rowspan="1" colspan="1">110 484 (16.3)</td><td valign="top" align="center" rowspan="1" colspan="1">109 069 (16.3)</td><td valign="top" align="center" rowspan="1" colspan="1">1415 (12.6)</td><td valign="top" align="center" rowspan="1" colspan="1">414 (12.8)</td><td valign="top" align="center" rowspan="1" colspan="1">646 (11.9)</td><td valign="top" align="center" rowspan="1" colspan="1">355 (14.1)</td><td valign="top" align="center" rowspan="1" colspan="1">6833 (16.5)</td><td valign="top" align="center" rowspan="1" colspan="1">1404 (12.7)</td><td valign="top" align="center" rowspan="1" colspan="1">0.11</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Q4</td><td valign="top" align="center" rowspan="1" colspan="1">96 892 (14.3)</td><td valign="top" align="center" rowspan="1" colspan="1">95 904 (14.3)</td><td valign="top" align="center" rowspan="1" colspan="1">988 (8.8)</td><td valign="top" align="center" rowspan="1" colspan="1">323 (10.0)</td><td valign="top" align="center" rowspan="1" colspan="1">465 (8.5)</td><td valign="top" align="center" rowspan="1" colspan="1">200 (7.9)</td><td valign="top" align="center" rowspan="1" colspan="1">5543 (13.4)</td><td valign="top" align="center" rowspan="1" colspan="1">976 (8.8)</td><td valign="top" align="center" rowspan="1" colspan="1">0.15</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Q5 (highest)</td><td valign="top" align="center" rowspan="1" colspan="1">90 785 (13.4)</td><td valign="top" align="center" rowspan="1" colspan="1">89 899 (13.4)</td><td valign="top" align="center" rowspan="1" colspan="1">886 (7.9)</td><td valign="top" align="center" rowspan="1" colspan="1">282 (8.7)</td><td valign="top" align="center" rowspan="1" colspan="1">416 (7.6)</td><td valign="top" align="center" rowspan="1" colspan="1">188 (7.4)</td><td valign="top" align="center" rowspan="1" colspan="1">5150 (12.5)</td><td valign="top" align="center" rowspan="1" colspan="1">873 (7.9)</td><td valign="top" align="center" rowspan="1" colspan="1">0.15</td></tr><tr><td colspan="10" valign="top" align="left" rowspan="1">Rurality</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Rural</td><td valign="top" align="center" rowspan="1" colspan="1">90 337 (13.3)</td><td valign="top" align="center" rowspan="1" colspan="1">88 922 (13.3)</td><td valign="top" align="center" rowspan="1" colspan="1">1415 (12.6)</td><td valign="top" align="center" rowspan="1" colspan="1">502 (15.6)</td><td valign="top" align="center" rowspan="1" colspan="1">659 (12.1)</td><td valign="top" align="center" rowspan="1" colspan="1">254 (10.1)</td><td valign="top" align="center" rowspan="1" colspan="1">5363 (13.0)</td><td valign="top" align="center" rowspan="1" colspan="1">1403 (12.6)</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Urban</td><td valign="top" align="center" rowspan="1" colspan="1">586 415 (86.3)</td><td valign="top" align="center" rowspan="1" colspan="1">576 773 (86.3)</td><td valign="top" align="center" rowspan="1" colspan="1">9642 (86.1)</td><td valign="top" align="center" rowspan="1" colspan="1">2686 (83.2)</td><td valign="top" align="center" rowspan="1" colspan="1">4741 (87.0)</td><td valign="top" align="center" rowspan="1" colspan="1">2215 (87.7)</td><td valign="top" align="center" rowspan="1" colspan="1">35 777 (86.6)</td><td valign="top" align="center" rowspan="1" colspan="1">9654 (86.1)</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Missing</td><td valign="top" align="center" rowspan="1" colspan="1">3088 (0.5)</td><td valign="top" align="center" rowspan="1" colspan="1">2945 (0.4)</td><td valign="top" align="center" rowspan="1" colspan="1">143 (1.3)</td><td valign="top" align="center" rowspan="1" colspan="1">39 (1.2)</td><td valign="top" align="center" rowspan="1" colspan="1">49 (0.9)</td><td valign="top" align="center" rowspan="1" colspan="1">55 (2.2)</td><td valign="top" align="center" rowspan="1" colspan="1">185 (0.4)</td><td valign="top" align="center" rowspan="1" colspan="1">143 (1.3)</td><td valign="top" align="center" rowspan="1" colspan="1">0.09</td></tr><tr><td colspan="10" valign="top" align="left" rowspan="1">Age and labour force marginalization quintile</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Missing</td><td valign="top" align="center" rowspan="1" colspan="1">8667 (1.3)</td><td valign="top" align="center" rowspan="1" colspan="1">8247 (1.2)</td><td valign="top" align="center" rowspan="1" colspan="1">420 (3.8)</td><td valign="top" align="center" rowspan="1" colspan="1">103 (3.2)</td><td valign="top" align="center" rowspan="1" colspan="1">194 (3.6)</td><td valign="top" align="center" rowspan="1" colspan="1">123 (4.9)</td><td valign="top" align="center" rowspan="1" colspan="1">818 (2.0)</td><td valign="top" align="center" rowspan="1" colspan="1">417 (3.8)</td><td valign="top" align="center" rowspan="1" colspan="1">0.11</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Q1 (lowest)</td><td valign="top" align="center" rowspan="1" colspan="1">85 736 (12.6)</td><td valign="top" align="center" rowspan="1" colspan="1">83 798 (12.5)</td><td valign="top" align="center" rowspan="1" colspan="1">1938 (17.3)</td><td valign="top" align="center" rowspan="1" colspan="1">480 (14.9)</td><td valign="top" align="center" rowspan="1" colspan="1">972 (17.8)</td><td valign="top" align="center" rowspan="1" colspan="1">486 (19.3)</td><td valign="top" align="center" rowspan="1" colspan="1">8396 (20.3)</td><td valign="top" align="center" rowspan="1" colspan="1">1916 (17.3)</td><td valign="top" align="center" rowspan="1" colspan="1">0.08</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Q2</td><td valign="top" align="center" rowspan="1" colspan="1">101 996 (15.0)</td><td valign="top" align="center" rowspan="1" colspan="1">99 772 (14.9)</td><td valign="top" align="center" rowspan="1" colspan="1">2224 (19.9)</td><td valign="top" align="center" rowspan="1" colspan="1">578 (17.9)</td><td valign="top" align="center" rowspan="1" colspan="1">1105 (20.3)</td><td valign="top" align="center" rowspan="1" colspan="1">541 (21.4)</td><td valign="top" align="center" rowspan="1" colspan="1">7923 (19.2)</td><td valign="top" align="center" rowspan="1" colspan="1">2195 (19.8)</td><td valign="top" align="center" rowspan="1" colspan="1">0.02</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Q3</td><td valign="top" align="center" rowspan="1" colspan="1">109 042 (16.0)</td><td valign="top" align="center" rowspan="1" colspan="1">107 154 (16.0)</td><td valign="top" align="center" rowspan="1" colspan="1">1888 (16.9)</td><td valign="top" align="center" rowspan="1" colspan="1">503 (15.6)</td><td valign="top" align="center" rowspan="1" colspan="1">953 (17.5)</td><td valign="top" align="center" rowspan="1" colspan="1">432 (17.1)</td><td valign="top" align="center" rowspan="1" colspan="1">7307 (17.7)</td><td valign="top" align="center" rowspan="1" colspan="1">1866 (16.8)</td><td valign="top" align="center" rowspan="1" colspan="1">0.02</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Q4</td><td valign="top" align="center" rowspan="1" colspan="1">127 464 (18.7)</td><td valign="top" align="center" rowspan="1" colspan="1">125 521 (18.8)</td><td valign="top" align="center" rowspan="1" colspan="1">1943 (17.3)</td><td valign="top" align="center" rowspan="1" colspan="1">546 (16.9)</td><td valign="top" align="center" rowspan="1" colspan="1">979 (18.0)</td><td valign="top" align="center" rowspan="1" colspan="1">418 (16.6)</td><td valign="top" align="center" rowspan="1" colspan="1">7360 (17.8)</td><td valign="top" align="center" rowspan="1" colspan="1">1931 (17.4)</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Q5 (highest)</td><td valign="top" align="center" rowspan="1" colspan="1">246 935 (36.3)</td><td valign="top" align="center" rowspan="1" colspan="1">244 148 (36.5)</td><td valign="top" align="center" rowspan="1" colspan="1">2787 (24.9)</td><td valign="top" align="center" rowspan="1" colspan="1">1017 (31.5)</td><td valign="top" align="center" rowspan="1" colspan="1">1246 (22.9)</td><td valign="top" align="center" rowspan="1" colspan="1">524 (20.8)</td><td valign="top" align="center" rowspan="1" colspan="1">9521 (23.0)</td><td valign="top" align="center" rowspan="1" colspan="1">2771 (25.0)</td><td valign="top" align="center" rowspan="1" colspan="1">0.05</td></tr><tr><td colspan="10" valign="top" align="left" rowspan="1">Material resources marginalization quintile</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Missing</td><td valign="top" align="center" rowspan="1" colspan="1">8667 (1.3)</td><td valign="top" align="center" rowspan="1" colspan="1">8247 (1.2)</td><td valign="top" align="center" rowspan="1" colspan="1">420 (3.8)</td><td valign="top" align="center" rowspan="1" colspan="1">103 (3.2)</td><td valign="top" align="center" rowspan="1" colspan="1">194 (3.6)</td><td valign="top" align="center" rowspan="1" colspan="1">123 (4.9)</td><td valign="top" align="center" rowspan="1" colspan="1">818 (2.0)</td><td valign="top" align="center" rowspan="1" colspan="1">417 (3.8)</td><td valign="top" align="center" rowspan="1" colspan="1">0.11</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Q1 (lowest)</td><td valign="top" align="center" rowspan="1" colspan="1">118 678 (17.5)</td><td valign="top" align="center" rowspan="1" colspan="1">117 556 (17.6)</td><td valign="top" align="center" rowspan="1" colspan="1">1122 (10.0)</td><td valign="top" align="center" rowspan="1" colspan="1">374 (11.6)</td><td valign="top" align="center" rowspan="1" colspan="1">508 (9.3)</td><td valign="top" align="center" rowspan="1" colspan="1">240 (9.5)</td><td valign="top" align="center" rowspan="1" colspan="1">6397 (15.5)</td><td valign="top" align="center" rowspan="1" colspan="1">1111 (10.0)</td><td valign="top" align="center" rowspan="1" colspan="1">0.16</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Q2</td><td valign="top" align="center" rowspan="1" colspan="1">126 149 (18.6)</td><td valign="top" align="center" rowspan="1" colspan="1">124 709 (18.7)</td><td valign="top" align="center" rowspan="1" colspan="1">1440 (12.9)</td><td valign="top" align="center" rowspan="1" colspan="1">515 (16.0)</td><td valign="top" align="center" rowspan="1" colspan="1">625 (11.5)</td><td valign="top" align="center" rowspan="1" colspan="1">300 (11.9)</td><td valign="top" align="center" rowspan="1" colspan="1">6888 (16.7)</td><td valign="top" align="center" rowspan="1" colspan="1">1427 (12.9)</td><td valign="top" align="center" rowspan="1" colspan="1">0.11</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Q3</td><td valign="top" align="center" rowspan="1" colspan="1">130 445 (19.2)</td><td valign="top" align="center" rowspan="1" colspan="1">128 835 (19.3)</td><td valign="top" align="center" rowspan="1" colspan="1">1610 (14.4)</td><td valign="top" align="center" rowspan="1" colspan="1">489 (15.2)</td><td valign="top" align="center" rowspan="1" colspan="1">746 (13.7)</td><td valign="top" align="center" rowspan="1" colspan="1">375 (14.9)</td><td valign="top" align="center" rowspan="1" colspan="1">7446 (18.0)</td><td valign="top" align="center" rowspan="1" colspan="1">1591 (14.3)</td><td valign="top" align="center" rowspan="1" colspan="1">0.1</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Q4</td><td valign="top" align="center" rowspan="1" colspan="1">137 919 (20.3)</td><td valign="top" align="center" rowspan="1" colspan="1">135 735 (20.3)</td><td valign="top" align="center" rowspan="1" colspan="1">2184 (19.5)</td><td valign="top" align="center" rowspan="1" colspan="1">616 (19.1)</td><td valign="top" align="center" rowspan="1" colspan="1">1101 (20.2)</td><td valign="top" align="center" rowspan="1" colspan="1">467 (18.5)</td><td valign="top" align="center" rowspan="1" colspan="1">8426 (20.4)</td><td valign="top" align="center" rowspan="1" colspan="1">2165 (19.5)</td><td valign="top" align="center" rowspan="1" colspan="1">0.02</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Q5 (highest)</td><td valign="top" align="center" rowspan="1" colspan="1">157 982 (23.2)</td><td valign="top" align="center" rowspan="1" colspan="1">153 558 (23.0)</td><td valign="top" align="center" rowspan="1" colspan="1">4424 (39.5)</td><td valign="top" align="center" rowspan="1" colspan="1">1130 (35.0)</td><td valign="top" align="center" rowspan="1" colspan="1">2275 (41.8)</td><td valign="top" align="center" rowspan="1" colspan="1">1019 (40.4)</td><td valign="top" align="center" rowspan="1" colspan="1">11 350 (27.5)</td><td valign="top" align="center" rowspan="1" colspan="1">4385 (39.5)</td><td valign="top" align="center" rowspan="1" colspan="1">0.26</td></tr><tr><td colspan="10" valign="top" align="left" rowspan="1">Racialized and newcomer populations marginalization quintile</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Missing</td><td valign="top" align="center" rowspan="1" colspan="1">8667 (1.3)</td><td valign="top" align="center" rowspan="1" colspan="1">8247 (1.2)</td><td valign="top" align="center" rowspan="1" colspan="1">420 (3.8)</td><td valign="top" align="center" rowspan="1" colspan="1">103 (3.2)</td><td valign="top" align="center" rowspan="1" colspan="1">194 (3.6)</td><td valign="top" align="center" rowspan="1" colspan="1">123 (4.9)</td><td valign="top" align="center" rowspan="1" colspan="1">818 (2.0)</td><td valign="top" align="center" rowspan="1" colspan="1">417 (3.8)</td><td valign="top" align="center" rowspan="1" colspan="1">0.11</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Q1 (lowest)</td><td valign="top" align="center" rowspan="1" colspan="1">151 479 (22.3)</td><td valign="top" align="center" rowspan="1" colspan="1">149 330 (22.3)</td><td valign="top" align="center" rowspan="1" colspan="1">2149 (19.2)</td><td valign="top" align="center" rowspan="1" colspan="1">703 (21.8)</td><td valign="top" align="center" rowspan="1" colspan="1">1002 (18.4)</td><td valign="top" align="center" rowspan="1" colspan="1">444 (17.6)</td><td valign="top" align="center" rowspan="1" colspan="1">8068 (19.5)</td><td valign="top" align="center" rowspan="1" colspan="1">2130 (19.2)</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Q2</td><td valign="top" align="center" rowspan="1" colspan="1">145 980 (21.5)</td><td valign="top" align="center" rowspan="1" colspan="1">143 657 (21.5)</td><td valign="top" align="center" rowspan="1" colspan="1">2323 (20.7)</td><td valign="top" align="center" rowspan="1" colspan="1">722 (22.4)</td><td valign="top" align="center" rowspan="1" colspan="1">1129 (20.7)</td><td valign="top" align="center" rowspan="1" colspan="1">472 (18.7)</td><td valign="top" align="center" rowspan="1" colspan="1">7879 (19.1)</td><td valign="top" align="center" rowspan="1" colspan="1">2301 (20.7)</td><td valign="top" align="center" rowspan="1" colspan="1">0.04</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Q3</td><td valign="top" align="center" rowspan="1" colspan="1">128 117 (18.8)</td><td valign="top" align="center" rowspan="1" colspan="1">125 797 (18.8)</td><td valign="top" align="center" rowspan="1" colspan="1">2320 (20.7)</td><td valign="top" align="center" rowspan="1" colspan="1">643 (19.9)</td><td valign="top" align="center" rowspan="1" colspan="1">1170 (21.5)</td><td valign="top" align="center" rowspan="1" colspan="1">507 (20.1)</td><td valign="top" align="center" rowspan="1" colspan="1">7601 (18.4)</td><td valign="top" align="center" rowspan="1" colspan="1">2298 (20.7)</td><td valign="top" align="center" rowspan="1" colspan="1">0.06</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Q4</td><td valign="top" align="center" rowspan="1" colspan="1">121 977 (17.9)</td><td valign="top" align="center" rowspan="1" colspan="1">119 781 (17.9)</td><td valign="top" align="center" rowspan="1" colspan="1">2196 (19.6)</td><td valign="top" align="center" rowspan="1" colspan="1">543 (16.8)</td><td valign="top" align="center" rowspan="1" colspan="1">1101 (20.2)</td><td valign="top" align="center" rowspan="1" colspan="1">552 (21.9)</td><td valign="top" align="center" rowspan="1" colspan="1">7761 (18.8)</td><td valign="top" align="center" rowspan="1" colspan="1">2174 (19.6)</td><td valign="top" align="center" rowspan="1" colspan="1">0.02</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Q5 (highest)</td><td valign="top" align="center" rowspan="1" colspan="1">123 620 (18.2)</td><td valign="top" align="center" rowspan="1" colspan="1">121 828 (18.2)</td><td valign="top" align="center" rowspan="1" colspan="1">1792 (16.0)</td><td valign="top" align="center" rowspan="1" colspan="1">513 (15.9)</td><td valign="top" align="center" rowspan="1" colspan="1">853 (15.7)</td><td valign="top" align="center" rowspan="1" colspan="1">426 (16.9)</td><td valign="top" align="center" rowspan="1" colspan="1">9198 (22.3)</td><td valign="top" align="center" rowspan="1" colspan="1">1776 (16.0)</td><td valign="top" align="center" rowspan="1" colspan="1">0.16</td></tr><tr><td colspan="10" valign="top" align="left" rowspan="1">Household and dwellings marginalization quintile</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Missing</td><td valign="top" align="center" rowspan="1" colspan="1">8667 (1.3)</td><td valign="top" align="center" rowspan="1" colspan="1">8247 (1.2)</td><td valign="top" align="center" rowspan="1" colspan="1">420 (3.8)</td><td valign="top" align="center" rowspan="1" colspan="1">103 (3.2)</td><td valign="top" align="center" rowspan="1" colspan="1">194 (3.6)</td><td valign="top" align="center" rowspan="1" colspan="1">123 (4.9)</td><td valign="top" align="center" rowspan="1" colspan="1">818 (2.0)</td><td valign="top" align="center" rowspan="1" colspan="1">417 (3.8)</td><td valign="top" align="center" rowspan="1" colspan="1">0.11</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Q1 (lowest)</td><td valign="top" align="center" rowspan="1" colspan="1">79 601 (11.7)</td><td valign="top" align="center" rowspan="1" colspan="1">78 848 (11.8)</td><td valign="top" align="center" rowspan="1" colspan="1">753 (6.7)</td><td valign="top" align="center" rowspan="1" colspan="1">224 (6.9)</td><td valign="top" align="center" rowspan="1" colspan="1">363 (6.7)</td><td valign="top" align="center" rowspan="1" colspan="1">166 (6.6)</td><td valign="top" align="center" rowspan="1" colspan="1">5795 (14.0)</td><td valign="top" align="center" rowspan="1" colspan="1">743 (6.7)</td><td valign="top" align="center" rowspan="1" colspan="1">0.24</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Q2</td><td valign="top" align="center" rowspan="1" colspan="1">104 479 (15.4)</td><td valign="top" align="center" rowspan="1" colspan="1">103 321 (15.5)</td><td valign="top" align="center" rowspan="1" colspan="1">1158 (10.3)</td><td valign="top" align="center" rowspan="1" colspan="1">373 (11.6)</td><td valign="top" align="center" rowspan="1" colspan="1">549 (10.1)</td><td valign="top" align="center" rowspan="1" colspan="1">236 (9.4)</td><td valign="top" align="center" rowspan="1" colspan="1">6505 (15.7)</td><td valign="top" align="center" rowspan="1" colspan="1">1147 (10.3)</td><td valign="top" align="center" rowspan="1" colspan="1">0.16</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Q3</td><td valign="top" align="center" rowspan="1" colspan="1">125 049 (18.4)</td><td valign="top" align="center" rowspan="1" colspan="1">123 504 (18.5)</td><td valign="top" align="center" rowspan="1" colspan="1">1545 (13.8)</td><td valign="top" align="center" rowspan="1" colspan="1">486 (15.1)</td><td valign="top" align="center" rowspan="1" colspan="1">766 (14.1)</td><td valign="top" align="center" rowspan="1" colspan="1">293 (11.6)</td><td valign="top" align="center" rowspan="1" colspan="1">7215 (17.5)</td><td valign="top" align="center" rowspan="1" colspan="1">1523 (13.7)</td><td valign="top" align="center" rowspan="1" colspan="1">0.10</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Q4</td><td valign="top" align="center" rowspan="1" colspan="1">151 855 (22.3)</td><td valign="top" align="center" rowspan="1" colspan="1">149 314 (22.3)</td><td valign="top" align="center" rowspan="1" colspan="1">2541 (22.7)</td><td valign="top" align="center" rowspan="1" colspan="1">757 (23.5)</td><td valign="top" align="center" rowspan="1" colspan="1">1236 (22.7)</td><td valign="top" align="center" rowspan="1" colspan="1">548 (21.7)</td><td valign="top" align="center" rowspan="1" colspan="1">8840 (21.4)</td><td valign="top" align="center" rowspan="1" colspan="1">2518 (22.7)</td><td valign="top" align="center" rowspan="1" colspan="1">0.03</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Q5</td><td valign="top" align="center" rowspan="1" colspan="1">210 189 (30.9)</td><td valign="top" align="center" rowspan="1" colspan="1">205 406 (30.7)</td><td valign="top" align="center" rowspan="1" colspan="1">4783 (42.7)</td><td valign="top" align="center" rowspan="1" colspan="1">1284 (39.8)</td><td valign="top" align="center" rowspan="1" colspan="1">2341 (43.0)</td><td valign="top" align="center" rowspan="1" colspan="1">1158 (45.9)</td><td valign="top" align="center" rowspan="1" colspan="1">12 152 (29.4)</td><td valign="top" align="center" rowspan="1" colspan="1">4748 (42.8)</td><td valign="top" align="center" rowspan="1" colspan="1">0.28</td></tr><tr><td colspan="10" valign="top" align="left" rowspan="1">Immigrant status</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Immigrant</td><td valign="top" align="center" rowspan="1" colspan="1">49 635 (7.3)</td><td valign="top" align="center" rowspan="1" colspan="1">49 264 (7.4)</td><td valign="top" align="center" rowspan="1" colspan="1">371 (3.3)</td><td valign="top" align="center" rowspan="1" colspan="1">114 (3.5)</td><td valign="top" align="center" rowspan="1" colspan="1">187 (3.4)</td><td valign="top" align="center" rowspan="1" colspan="1">70 (2.8)</td><td valign="top" align="center" rowspan="1" colspan="1">4976 (12.0)</td><td valign="top" align="center" rowspan="1" colspan="1">366 (3.3)</td><td valign="top" align="center" rowspan="1" colspan="1">0.33</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Non-immigrant and missing</td><td valign="top" align="center" rowspan="1" colspan="1">630 205 (92.7)</td><td valign="top" align="center" rowspan="1" colspan="1">619 376 (92.6)</td><td valign="top" align="center" rowspan="1" colspan="1">10 829 (96.7)</td><td valign="top" align="center" rowspan="1" colspan="1">3113 (96.5)</td><td valign="top" align="center" rowspan="1" colspan="1">5262 (96.6)</td><td valign="top" align="center" rowspan="1" colspan="1">2454 (97.2)</td><td valign="top" align="center" rowspan="1" colspan="1">36 349 (88.0)</td><td valign="top" align="center" rowspan="1" colspan="1">10 730 (96.7)</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="tfn19-196e547"><p>Note: ED = emergency department, OAT = opioid agonist treatment, SD = standard deviation, Std Diff = standardized difference.</p></fn><fn id="tfn1-196e547"><label>*</label><p>Unless otherwise indicated.</p></fn><fn id="tfn2-196e547"><label>&#8224;</label><p>Decedents with OUD were matched to decedents without OUD group on age (&#177; 2 yr).</p></fn><fn id="tfn3-196e547"><label>&#8225;</label><p>Compares age-matched decedents with and without OUD.</p></fn><fn id="tfn4-196e547"><label>&#167;</label><p>Ranges presented to prevent back-calculation of small cell counts (&#8804; 5).</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="t2-196e547" orientation="portrait"><label>Table 2:</label><caption><p>Characteristics of decedent cohort related to comorbidities and chronic conditions, comparing those with a history of opioid use disorder (OUD) to those without OUD</p></caption><table frame="box" rules="rows"><thead><tr><th valign="bottom" rowspan="2" align="left" colspan="1">Characteristic</th><th colspan="8" valign="bottom" align="center" rowspan="1">No. (%) of decedents<xref rid="tfn5-196e547" ref-type="table-fn">*</xref></th><th valign="bottom" rowspan="2" align="center" colspan="1">Std Diff<xref rid="tfn7-196e547" ref-type="table-fn">&#8225;</xref></th></tr><tr><th valign="bottom" align="center" rowspan="1" colspan="1">Total<break/><italic toggle="yes">n</italic> = 679 840</th><th valign="bottom" align="center" rowspan="1" colspan="1">No OUD, total<break/><italic toggle="yes">n</italic> = 668 640</th><th valign="bottom" align="center" rowspan="1" colspan="1">OUD, total<break/><italic toggle="yes">n</italic> = 11 200</th><th valign="bottom" align="center" rowspan="1" colspan="1">OUD, hospital admissions or ED visits only<break/><italic toggle="yes">n</italic> = 3227</th><th valign="bottom" align="center" rowspan="1" colspan="1">OUD, OAT only<break/><italic toggle="yes">n</italic> = 5449</th><th valign="bottom" align="center" rowspan="1" colspan="1">OUD, hospital admissions or ED visits and OAT<break/><italic toggle="yes">n</italic> = 2524</th><th valign="bottom" align="center" rowspan="1" colspan="1">No OUD, age- matched<xref rid="tfn6-196e547" ref-type="table-fn">&#8224;</xref><break/><italic toggle="yes">n</italic> = 41 325</th><th valign="bottom" align="center" rowspan="1" colspan="1">OUD age- matched<xref rid="tfn6-196e547" ref-type="table-fn">&#8224;</xref><break/><italic toggle="yes">n</italic> = 11 096</th></tr></thead><tbody><tr><td colspan="10" valign="top" align="left" rowspan="1">No. of active comorbidities</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;0</td><td valign="top" align="center" rowspan="1" colspan="1">53 388 (7.9)</td><td valign="top" align="center" rowspan="1" colspan="1">51 807 (7.7)</td><td valign="top" align="center" rowspan="1" colspan="1">1581 (14.1)</td><td valign="top" align="center" rowspan="1" colspan="1">121 (3.7)</td><td valign="top" align="center" rowspan="1" colspan="1">1178 (21.6)</td><td valign="top" align="center" rowspan="1" colspan="1">282 (11.2)</td><td valign="top" align="center" rowspan="1" colspan="1">7898 (19.1)</td><td valign="top" align="center" rowspan="1" colspan="1">1553 (14.0)</td><td valign="top" align="center" rowspan="1" colspan="1">0.14</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;1</td><td valign="top" align="center" rowspan="1" colspan="1">114 010 (16.8)</td><td valign="top" align="center" rowspan="1" colspan="1">111 744 (16.7)</td><td valign="top" align="center" rowspan="1" colspan="1">2266 (20.2)</td><td valign="top" align="center" rowspan="1" colspan="1">356 (11.0)</td><td valign="top" align="center" rowspan="1" colspan="1">1383 (25.4)</td><td valign="top" align="center" rowspan="1" colspan="1">527 (20.9)</td><td valign="top" align="center" rowspan="1" colspan="1">10 298 (24.9)</td><td valign="top" align="center" rowspan="1" colspan="1">2233 (20.1)</td><td valign="top" align="center" rowspan="1" colspan="1">0.12</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;2</td><td valign="top" align="center" rowspan="1" colspan="1">137 374 (20.2)</td><td valign="top" align="center" rowspan="1" colspan="1">134 883 (20.2)</td><td valign="top" align="center" rowspan="1" colspan="1">2491 (22.2)</td><td valign="top" align="center" rowspan="1" colspan="1">583 (18.1)</td><td valign="top" align="center" rowspan="1" colspan="1">1219 (22.4)</td><td valign="top" align="center" rowspan="1" colspan="1">689 (27.3)</td><td valign="top" align="center" rowspan="1" colspan="1">9417 (22.8)</td><td valign="top" align="center" rowspan="1" colspan="1">2457 (22.1)</td><td valign="top" align="center" rowspan="1" colspan="1">0.02</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;3</td><td valign="top" align="center" rowspan="1" colspan="1">125 009 (18.4)</td><td valign="top" align="center" rowspan="1" colspan="1">123 347 (18.4)</td><td valign="top" align="center" rowspan="1" colspan="1">1662 (14.8)</td><td valign="top" align="center" rowspan="1" colspan="1">520 (16.1)</td><td valign="top" align="center" rowspan="1" colspan="1">704 (12.9)</td><td valign="top" align="center" rowspan="1" colspan="1">438 (17.4)</td><td valign="top" align="center" rowspan="1" colspan="1">5815 (14.1)</td><td valign="top" align="center" rowspan="1" colspan="1">1656 (14.9)</td><td valign="top" align="center" rowspan="1" colspan="1">0.02</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;4</td><td valign="top" align="center" rowspan="1" colspan="1">97 588 (14.4)</td><td valign="top" align="center" rowspan="1" colspan="1">96 420 (14.4)</td><td valign="top" align="center" rowspan="1" colspan="1">1168 (10.4)</td><td valign="top" align="center" rowspan="1" colspan="1">481 (14.9)</td><td valign="top" align="center" rowspan="1" colspan="1">434 (8.0)</td><td valign="top" align="center" rowspan="1" colspan="1">253 (10.0)</td><td valign="top" align="center" rowspan="1" colspan="1">3579 (8.7)</td><td valign="top" align="center" rowspan="1" colspan="1">1165 (10.5)</td><td valign="top" align="center" rowspan="1" colspan="1">0.06</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;5</td><td valign="top" align="center" rowspan="1" colspan="1">67 604 (9.9)</td><td valign="top" align="center" rowspan="1" colspan="1">66 782 (10.0)</td><td valign="top" align="center" rowspan="1" colspan="1">822 (7.3)</td><td valign="top" align="center" rowspan="1" colspan="1">419 (13.0)</td><td valign="top" align="center" rowspan="1" colspan="1">258 (4.7)</td><td valign="top" align="center" rowspan="1" colspan="1">145 (5.7)</td><td valign="top" align="center" rowspan="1" colspan="1">2062 (5.0)</td><td valign="top" align="center" rowspan="1" colspan="1">822 (7.4)</td><td valign="top" align="center" rowspan="1" colspan="1">0.1</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;6</td><td valign="top" align="center" rowspan="1" colspan="1">42 681 (6.3)</td><td valign="top" align="center" rowspan="1" colspan="1">42 150 (6.3)</td><td valign="top" align="center" rowspan="1" colspan="1">531 (4.7)</td><td valign="top" align="center" rowspan="1" colspan="1">294 (9.1)</td><td valign="top" align="center" rowspan="1" colspan="1">146 (2.7)</td><td valign="top" align="center" rowspan="1" colspan="1">91 (3.6)</td><td valign="top" align="center" rowspan="1" colspan="1">1155 (2.8)</td><td valign="top" align="center" rowspan="1" colspan="1">531 (4.8)</td><td valign="top" align="center" rowspan="1" colspan="1">0.1</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;&#8805; 7</td><td valign="top" align="center" rowspan="1" colspan="1">42 186 (6.2)</td><td valign="top" align="center" rowspan="1" colspan="1">41 507 (6.2)</td><td valign="top" align="center" rowspan="1" colspan="1">679 (6.1)</td><td valign="top" align="center" rowspan="1" colspan="1">453 (14.0)</td><td valign="top" align="center" rowspan="1" colspan="1">127 (2.3)</td><td valign="top" align="center" rowspan="1" colspan="1">99 (3.9)</td><td valign="top" align="center" rowspan="1" colspan="1">1101 (2.7)</td><td valign="top" align="center" rowspan="1" colspan="1">679 (6.1)</td><td valign="top" align="center" rowspan="1" colspan="1">0.17</td></tr><tr><td colspan="10" valign="top" align="left" rowspan="1">Charlson Comorbidity Index</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;0</td><td valign="top" align="center" rowspan="1" colspan="1">68 277 (10.0)</td><td valign="top" align="center" rowspan="1" colspan="1">65 974 (9.9)</td><td valign="top" align="center" rowspan="1" colspan="1">2303 (20.6)</td><td valign="top" align="center" rowspan="1" colspan="1">655 (20.3)</td><td valign="top" align="center" rowspan="1" colspan="1">891 (16.4)</td><td valign="top" align="center" rowspan="1" colspan="1">757 (30.0)</td><td valign="top" align="center" rowspan="1" colspan="1">4485 (10.9)</td><td valign="top" align="center" rowspan="1" colspan="1">2271 (20.5)</td><td valign="top" align="center" rowspan="1" colspan="1">0.27</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;1</td><td valign="top" align="center" rowspan="1" colspan="1">76 864 (11.3)</td><td valign="top" align="center" rowspan="1" colspan="1">75 580 (11.3)</td><td valign="top" align="center" rowspan="1" colspan="1">1284 (11.5)</td><td valign="top" align="center" rowspan="1" colspan="1">419 (13.0)</td><td valign="top" align="center" rowspan="1" colspan="1">449 (8.2)</td><td valign="top" align="center" rowspan="1" colspan="1">416 (16.5)</td><td valign="top" align="center" rowspan="1" colspan="1">2629 (6.4)</td><td valign="top" align="center" rowspan="1" colspan="1">1278 (11.5)</td><td valign="top" align="center" rowspan="1" colspan="1">0.18</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;&#8805; 2</td><td valign="top" align="center" rowspan="1" colspan="1">252 507 (37.1)</td><td valign="top" align="center" rowspan="1" colspan="1">249 095 (37.3)</td><td valign="top" align="center" rowspan="1" colspan="1">3412 (30.5)</td><td valign="top" align="center" rowspan="1" colspan="1">1713 (53.1)</td><td valign="top" align="center" rowspan="1" colspan="1">993 (18.2)</td><td valign="top" align="center" rowspan="1" colspan="1">706 (28.0)</td><td valign="top" align="center" rowspan="1" colspan="1">13 103 (31.7)</td><td valign="top" align="center" rowspan="1" colspan="1">3405 (30.7)</td><td valign="top" align="center" rowspan="1" colspan="1">0.02</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Mean &#177; SD</td><td valign="top" align="center" rowspan="1" colspan="1">2.75 &#177; 2.34</td><td valign="top" align="center" rowspan="1" colspan="1">2.76 &#177; 2.34</td><td valign="top" align="center" rowspan="1" colspan="1">2.21 &#177; 2.45</td><td valign="top" align="center" rowspan="1" colspan="1">2.76 &#177; 2.55</td><td valign="top" align="center" rowspan="1" colspan="1">1.91 &#177; 2.32</td><td valign="top" align="center" rowspan="1" colspan="1">1.76 &#177; 2.31</td><td valign="top" align="center" rowspan="1" colspan="1">3.01 &#177; 2.58</td><td valign="top" align="center" rowspan="1" colspan="1">2.22 &#177; 2.45</td><td valign="top" align="center" rowspan="1" colspan="1">0.31</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Median (IQR)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (1&#8211;4)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (1&#8211;4)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (0&#8211;3)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (1&#8211;4)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (0&#8211;3)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (0&#8211;3)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (1&#8211;6)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (0&#8211;3)</td><td valign="top" align="center" rowspan="1" colspan="1">0.34</td></tr><tr><td colspan="10" valign="top" align="left" rowspan="1">Chronic conditions</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Coronary artery disease</td><td valign="top" align="center" rowspan="1" colspan="1">108 272 (15.9)</td><td valign="top" align="center" rowspan="1" colspan="1">107 434 (16.1)</td><td valign="top" align="center" rowspan="1" colspan="1">838 (7.5)</td><td valign="top" align="center" rowspan="1" colspan="1">455 (14.1)</td><td valign="top" align="center" rowspan="1" colspan="1">265 (4.9)</td><td valign="top" align="center" rowspan="1" colspan="1">118 (4.7)</td><td valign="top" align="center" rowspan="1" colspan="1">2991 (7.2)</td><td valign="top" align="center" rowspan="1" colspan="1">837 (7.5)</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Cancer</td><td valign="top" align="center" rowspan="1" colspan="1">272 410 (40.1)</td><td valign="top" align="center" rowspan="1" colspan="1">270 244 (40.4)</td><td valign="top" align="center" rowspan="1" colspan="1">2166 (19.3)</td><td valign="top" align="center" rowspan="1" colspan="1">984 (30.5)</td><td valign="top" align="center" rowspan="1" colspan="1">883 (16.2)</td><td valign="top" align="center" rowspan="1" colspan="1">299 (11.8)</td><td valign="top" align="center" rowspan="1" colspan="1">14 127 (34.2)</td><td valign="top" align="center" rowspan="1" colspan="1">2161 (19.5)</td><td valign="top" align="center" rowspan="1" colspan="1">0.34</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Chronic heart failure</td><td valign="top" align="center" rowspan="1" colspan="1">144 859 (21.3)</td><td valign="top" align="center" rowspan="1" colspan="1">143 613 (21.5)</td><td valign="top" align="center" rowspan="1" colspan="1">1246 (11.1)</td><td valign="top" align="center" rowspan="1" colspan="1">718 (22.2)</td><td valign="top" align="center" rowspan="1" colspan="1">324 (5.9)</td><td valign="top" align="center" rowspan="1" colspan="1">204 (8.1)</td><td valign="top" align="center" rowspan="1" colspan="1">3460 (8.4)</td><td valign="top" align="center" rowspan="1" colspan="1">1246 (11.2)</td><td valign="top" align="center" rowspan="1" colspan="1">0.1</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;COPD</td><td valign="top" align="center" rowspan="1" colspan="1">104 362 (15.4)</td><td valign="top" align="center" rowspan="1" colspan="1">102 433 (15.3)</td><td valign="top" align="center" rowspan="1" colspan="1">1929 (17.2)</td><td valign="top" align="center" rowspan="1" colspan="1">867 (26.9)</td><td valign="top" align="center" rowspan="1" colspan="1">694 (12.7)</td><td valign="top" align="center" rowspan="1" colspan="1">368 (14.6)</td><td valign="top" align="center" rowspan="1" colspan="1">3373 (8.2)</td><td valign="top" align="center" rowspan="1" colspan="1">1929 (17.4)</td><td valign="top" align="center" rowspan="1" colspan="1">0.28</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Dementia</td><td valign="top" align="center" rowspan="1" colspan="1">89 297 (13.1)</td><td valign="top" align="center" rowspan="1" colspan="1">89 155 (13.3)</td><td valign="top" align="center" rowspan="1" colspan="1">142 (1.3)</td><td valign="top" align="center" rowspan="1" colspan="1">121&#8211;125<xref rid="tfn10-196e547" ref-type="table-fn">**</xref></td><td valign="top" align="center" rowspan="1" colspan="1">16 (0.3)</td><td valign="top" align="center" rowspan="1" colspan="1">1&#8211;5<xref rid="tfn10-196e547" ref-type="table-fn">**</xref></td><td valign="top" align="center" rowspan="1" colspan="1">987 (2.4)</td><td valign="top" align="center" rowspan="1" colspan="1">142 (1.3)</td><td valign="top" align="center" rowspan="1" colspan="1">0.08</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Diabetes</td><td valign="top" align="center" rowspan="1" colspan="1">212 955 (31.3)</td><td valign="top" align="center" rowspan="1" colspan="1">210 788 (31.5)</td><td valign="top" align="center" rowspan="1" colspan="1">2167 (19.3)</td><td valign="top" align="center" rowspan="1" colspan="1">1016 (31.5)</td><td valign="top" align="center" rowspan="1" colspan="1">772 (14.2)</td><td valign="top" align="center" rowspan="1" colspan="1">379 (15.0)</td><td valign="top" align="center" rowspan="1" colspan="1">8768 (21.2)</td><td valign="top" align="center" rowspan="1" colspan="1">2165 (19.5)</td><td valign="top" align="center" rowspan="1" colspan="1">0.04</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Hepatitis C<xref rid="tfn8-196e547" ref-type="table-fn">&#167;</xref></td><td valign="top" align="center" rowspan="1" colspan="1">5561 (0.8)</td><td valign="top" align="center" rowspan="1" colspan="1">3891 (0.6)</td><td valign="top" align="center" rowspan="1" colspan="1">1670 (14.9)</td><td valign="top" align="center" rowspan="1" colspan="1">336 (10.4)</td><td valign="top" align="center" rowspan="1" colspan="1">631 (11.6)</td><td valign="top" align="center" rowspan="1" colspan="1">703 (27.9)</td><td valign="top" align="center" rowspan="1" colspan="1">550 (1.3)</td><td valign="top" align="center" rowspan="1" colspan="1">1658 (14.9)</td><td valign="top" align="center" rowspan="1" colspan="1">0.51</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;HIV<xref rid="tfn6-196e547" ref-type="table-fn">&#8224;</xref></td><td valign="top" align="center" rowspan="1" colspan="1">1653 (0.2)</td><td valign="top" align="center" rowspan="1" colspan="1">1416 (0.2)</td><td valign="top" align="center" rowspan="1" colspan="1">237 (2.1)</td><td valign="top" align="center" rowspan="1" colspan="1">54 (1.7)</td><td valign="top" align="center" rowspan="1" colspan="1">88 (1.6)</td><td valign="top" align="center" rowspan="1" colspan="1">95 (3.8)</td><td valign="top" align="center" rowspan="1" colspan="1">282 (0.7)</td><td valign="top" align="center" rowspan="1" colspan="1">236 (2.1)</td><td valign="top" align="center" rowspan="1" colspan="1">0.12</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Infective endocarditis</td><td valign="top" align="center" rowspan="1" colspan="1">1784 (0.3)</td><td valign="top" align="center" rowspan="1" colspan="1">1430 (0.2)</td><td valign="top" align="center" rowspan="1" colspan="1">354 (3.2)</td><td valign="top" align="center" rowspan="1" colspan="1">77 (2.4)</td><td valign="top" align="center" rowspan="1" colspan="1">66 (1.2)</td><td valign="top" align="center" rowspan="1" colspan="1">211 (1.2)</td><td valign="top" align="center" rowspan="1" colspan="1">125 (0.3)</td><td valign="top" align="center" rowspan="1" colspan="1">354 (3.1)</td><td valign="top" align="center" rowspan="1" colspan="1">0.22</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Mental health disorder</td><td valign="top" align="center" rowspan="1" colspan="1">96 529 (14.2)</td><td valign="top" align="center" rowspan="1" colspan="1">92 124 (13.8)</td><td valign="top" align="center" rowspan="1" colspan="1">4405 (39.3)</td><td valign="top" align="center" rowspan="1" colspan="1">1535 (47.6)</td><td valign="top" align="center" rowspan="1" colspan="1">1565 (28.7)</td><td valign="top" align="center" rowspan="1" colspan="1">1305 (51.7)</td><td valign="top" align="center" rowspan="1" colspan="1">7752 (18.8)</td><td valign="top" align="center" rowspan="1" colspan="1">4363 (39.3)</td><td valign="top" align="center" rowspan="1" colspan="1">0.47</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Mood disorder</td><td valign="top" align="center" rowspan="1" colspan="1">162 726 (23.9)</td><td valign="top" align="center" rowspan="1" colspan="1">156 599 (23.4)</td><td valign="top" align="center" rowspan="1" colspan="1">6127 (54.7)</td><td valign="top" align="center" rowspan="1" colspan="1">1836 (56.9)</td><td valign="top" align="center" rowspan="1" colspan="1">2695 (49.5)</td><td valign="top" align="center" rowspan="1" colspan="1">1596 (63.2)</td><td valign="top" align="center" rowspan="1" colspan="1">13 671 (33.1)</td><td valign="top" align="center" rowspan="1" colspan="1">6068 (54.7)</td><td valign="top" align="center" rowspan="1" colspan="1">0.45</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Renal disease</td><td valign="top" align="center" rowspan="1" colspan="1">127 363 (18.7)</td><td valign="top" align="center" rowspan="1" colspan="1">125 533 (18.8)</td><td valign="top" align="center" rowspan="1" colspan="1">1830 (16.3)</td><td valign="top" align="center" rowspan="1" colspan="1">949 (29.4)</td><td valign="top" align="center" rowspan="1" colspan="1">444 (8.1)</td><td valign="top" align="center" rowspan="1" colspan="1">437 (17.3)</td><td valign="top" align="center" rowspan="1" colspan="1">4698 (11.4)</td><td valign="top" align="center" rowspan="1" colspan="1">1824 (16.4)</td><td valign="top" align="center" rowspan="1" colspan="1">0.15</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Stroke</td><td valign="top" align="center" rowspan="1" colspan="1">41 541 (6.1)</td><td valign="top" align="center" rowspan="1" colspan="1">41 279 (6.2)</td><td valign="top" align="center" rowspan="1" colspan="1">262 (2.3)</td><td valign="top" align="center" rowspan="1" colspan="1">137 (4.2)</td><td valign="top" align="center" rowspan="1" colspan="1">80 (1.5)</td><td valign="top" align="center" rowspan="1" colspan="1">45 (1.8)</td><td valign="top" align="center" rowspan="1" colspan="1">1204 (2.9)</td><td valign="top" align="center" rowspan="1" colspan="1">261 (2.4)</td><td valign="top" align="center" rowspan="1" colspan="1">0.04</td></tr><tr><td colspan="10" valign="top" align="left" rowspan="1">Other harmful substance use</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Benzodiazepine</td><td valign="top" align="center" rowspan="1" colspan="1">732 (0.1)</td><td valign="top" align="center" rowspan="1" colspan="1">516 (0.1)</td><td valign="top" align="center" rowspan="1" colspan="1">216 (1.9)</td><td valign="top" align="center" rowspan="1" colspan="1">54 (1.7)</td><td valign="top" align="center" rowspan="1" colspan="1">64 (1.2)</td><td valign="top" align="center" rowspan="1" colspan="1">98 (3.9)</td><td valign="top" align="center" rowspan="1" colspan="1">148 (0.4)</td><td valign="top" align="center" rowspan="1" colspan="1">215 (1.9)</td><td valign="top" align="center" rowspan="1" colspan="1">0.15</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Stimulant</td><td valign="top" align="center" rowspan="1" colspan="1">2115 (0.3)</td><td valign="top" align="center" rowspan="1" colspan="1">1030 (0.2)</td><td valign="top" align="center" rowspan="1" colspan="1">1085 (9.7)</td><td valign="top" align="center" rowspan="1" colspan="1">312 (9.7)</td><td valign="top" align="center" rowspan="1" colspan="1">273 (5.0)</td><td valign="top" align="center" rowspan="1" colspan="1">500 (19.8)</td><td valign="top" align="center" rowspan="1" colspan="1">548 (1.3)</td><td valign="top" align="center" rowspan="1" colspan="1">1069 (9.6)</td><td valign="top" align="center" rowspan="1" colspan="1">0.37</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Alcohol</td><td valign="top" align="center" rowspan="1" colspan="1">27 036 (4.0)</td><td valign="top" align="center" rowspan="1" colspan="1">25 048 (3.7)</td><td valign="top" align="center" rowspan="1" colspan="1">1988 (17.8)</td><td valign="top" align="center" rowspan="1" colspan="1">724 (22.4)</td><td valign="top" align="center" rowspan="1" colspan="1">613 (11.2)</td><td valign="top" align="center" rowspan="1" colspan="1">651 (25.8)</td><td valign="top" align="center" rowspan="1" colspan="1">3161 (7.6)</td><td valign="top" align="center" rowspan="1" colspan="1">1970 (17.8)</td><td valign="top" align="center" rowspan="1" colspan="1">0.31</td></tr></tbody></table><table-wrap-foot><fn id="tfn20-196e547"><p>Note: COPD = chronic obstructive pulmonary disease, ED = emergency department, IQR = interquartile range, OAT = opioid agonist treatment, SD = standard deviation, Std Diff = standardized difference.</p></fn><fn id="tfn5-196e547"><label>*</label><p>Unless otherwise indicated.</p></fn><fn id="tfn6-196e547"><label>&#8224;</label><p>Decedents with OUD were matched to decedents without OUD group on age (&#177; 2 yr).</p></fn><fn id="tfn7-196e547"><label>&#8225;</label><p>Compares age-matched decedents with and without OUD.</p></fn><fn id="tfn8-196e547"><label>&#167;</label><p>Lookback period of 5 years before index (90 d before death).</p></fn><fn id="tfn9-196e547"><label>&#182;</label><p>Lookback for any HIV diagnosis from birth to index (90 d before death).</p></fn><fn id="tfn10-196e547"><label>**</label><p>Ranges presented to prevent back-calculation of small cell counts (&#8804; 5).</p></fn></table-wrap-foot></table-wrap><p>People with OUD had higher prevalence of several clinical diagnoses, particularly hepatitis C (14.9% v. 1.3%, standardized difference 0.51), mood disorders (54.7% v. 33.1%, standardized difference 0.45), and other mental health disorders (39.3% v. 18.8%, standardized difference 0.47). People with OUD were also more likely to have a history of harms associated with alcohol (17.8% v. 7.6%, standardized difference 0.31) and stimulants (9.6% v. 1.3%, standardized difference 0.37). Appendix 6, available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="www.cmaj.ca/lookup/doi/10.1503/cmaj.231419/tab-related-content" ext-link-type="uri">www.cmaj.ca/lookup/doi/10.1503/cmaj.231419/tab-related-content</ext-link>, provides the top 10 specific causes of death for people with and without OUD.</p></sec><sec><title>Palliative care</title><p>We found 5063 people with OUD (45.2%) received palliative care in the last 90 days of life and, of these, 4392 (86.7%) received it in acute care hospitals (<xref rid="t3-196e547" ref-type="table">Table 3</xref>). In the age-matched cohort, and after adjustment for covariates, we found people with OUD were 16% less likely to receive palliative care than those without OUD (adjusted RR 0.84, 95% confidence interval [CI] 0.82&#8211;0.86). Specifically, people with OUD were less likely to receive palliative care in acute care hospitals (adjusted RR 0.87, 95% CI 0.85&#8211;0.89), in clinics (adjusted RR 0.68, 95% CI 0.64&#8211;0.71), at home (adjusted RR 0.62, 95% CI 0.59&#8211;0.66), and in long-term care facilities (adjusted RR 0.84, 95% CI 0.74&#8211;0.94). Palliative care intensity was 16% lower for people with OUD than those without OUD at the end of life (mean 14.3 v. 17.4 d, standardized difference 0.15; IRR 0.84, 95% CI 0.80&#8211;0.89). The most common diagnoses associated with palliative care assessments by physicians for decedents with OUD were lung cancer (8.3%), other cancers (5.3%), liver cirrhosis (3.4%), sepsis (3.4%), and pneumonia (2.7%). Appendix 7, available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="www.cmaj.ca/lookup/doi/10.1503/cmaj.231419/tab-related-content" ext-link-type="uri">www.cmaj.ca/lookup/doi/10.1503/cmaj.231419/tab-related-content</ext-link>, provides the top 10 diagnoses associated with palliative care assessments conducted by a physician for decedents with and without OUD.</p><table-wrap position="float" id="t3-196e547" orientation="portrait"><label>Table 3:</label><caption><p>Palliative care received overall and stratified by setting, and the intensity of palliative care received in the last 3 months of life, comparing those with a history of opioid use disorder (OUD) to those without OUD<xref rid="tfn11-196e547" ref-type="table-fn">*</xref></p></caption><table frame="box" rules="rows"><thead><tr><th valign="bottom" rowspan="2" align="left" colspan="1">Variable</th><th colspan="5" valign="bottom" align="center" rowspan="1">No. (%) of decedents<xref rid="tfn12-196e547" ref-type="table-fn">&#8224;</xref></th><th valign="bottom" rowspan="2" align="center" colspan="1">Unadjusted RR for all decedents (95% CI)</th><th valign="bottom" rowspan="2" align="center" colspan="1">Adjusted RR for all decedents (95% CI)</th></tr><tr><th valign="bottom" align="center" rowspan="1" colspan="1">Total<break/><italic toggle="yes">n</italic> = 679 840</th><th valign="bottom" align="center" rowspan="1" colspan="1">No OUD, total<break/><italic toggle="yes">n</italic> = 668 640</th><th valign="bottom" align="center" rowspan="1" colspan="1">OUD, total<break/><italic toggle="yes">n</italic> = 11 200</th><th valign="bottom" align="center" rowspan="1" colspan="1">No OUD, age- matched<xref rid="tfn13-196e547" ref-type="table-fn">&#8225;</xref><break/><italic toggle="yes">n</italic> = 41 325</th><th valign="bottom" align="center" rowspan="1" colspan="1">OUD, age- matched<xref rid="tfn13-196e547" ref-type="table-fn">&#8225;</xref><break/><italic toggle="yes">n</italic> = 11 096</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Any palliative care received</td><td valign="top" align="center" rowspan="1" colspan="1">489 135 (71.9)</td><td valign="top" align="center" rowspan="1" colspan="1">484 072 (72.4)</td><td valign="top" align="center" rowspan="1" colspan="1">5063 (45.2)</td><td valign="top" align="center" rowspan="1" colspan="1">23 502 (56.9)</td><td valign="top" align="center" rowspan="1" colspan="1">5029 (45.3)</td><td valign="top" align="center" rowspan="1" colspan="1">0.80 (0.78&#8211;0.82)</td><td valign="top" align="center" rowspan="1" colspan="1">0.84 (0.82&#8211;0.86)</td></tr><tr><td colspan="8" valign="top" align="left" rowspan="1">Palliative care setting</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Home</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.51 (0.48&#8211;0.54)</td><td valign="top" align="center" rowspan="1" colspan="1">0.62 (0.59&#8211;0.66)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;&#8195;Home care<xref rid="tfn14-196e547" ref-type="table-fn">&#167;</xref></td><td valign="top" align="center" rowspan="1" colspan="1">154 703 (22.8)</td><td valign="top" align="center" rowspan="1" colspan="1">153 575 (23.0)</td><td valign="top" align="center" rowspan="1" colspan="1">1128 (10.1)</td><td valign="top" align="center" rowspan="1" colspan="1">9105 (22.0)</td><td valign="top" align="center" rowspan="1" colspan="1">1125 (10.1)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;&#8195;Home MD visits</td><td valign="top" align="center" rowspan="1" colspan="1">132 425 (19.5)</td><td valign="top" align="center" rowspan="1" colspan="1">131 528 (19.7)</td><td valign="top" align="center" rowspan="1" colspan="1">897 (8.0)</td><td valign="top" align="center" rowspan="1" colspan="1">6337 (15.3)</td><td valign="top" align="center" rowspan="1" colspan="1">895 (8.1)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Clinic</td><td valign="top" align="center" rowspan="1" colspan="1">186 169 (27.4)</td><td valign="top" align="center" rowspan="1" colspan="1">184 610 (27.6)</td><td valign="top" align="center" rowspan="1" colspan="1">1559 (13.9)</td><td valign="top" align="center" rowspan="1" colspan="1">10 174 (24.6)</td><td valign="top" align="center" rowspan="1" colspan="1">1557 (14.0)</td><td valign="top" align="center" rowspan="1" colspan="1">0.57 (0.54&#8211;0.60)</td><td valign="top" align="center" rowspan="1" colspan="1">0.68 (0.64&#8211;0.71)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Acute care hospital</td><td valign="top" align="center" rowspan="1" colspan="1">346 405 (51.0)</td><td valign="top" align="center" rowspan="1" colspan="1">342 013 (51.2)</td><td valign="top" align="center" rowspan="1" colspan="1">4392 (39.2)</td><td valign="top" align="center" rowspan="1" colspan="1">19 032 (46.1)</td><td valign="top" align="center" rowspan="1" colspan="1">4359 (39.3)</td><td valign="top" align="center" rowspan="1" colspan="1">0.85 (0.83&#8211;0.88)</td><td valign="top" align="center" rowspan="1" colspan="1">0.87 (0.85&#8211;0.89)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Long-term care institute</td><td valign="top" align="center" rowspan="1" colspan="1">82 091 (12.1)</td><td valign="top" align="center" rowspan="1" colspan="1">81 772 (12.2)</td><td valign="top" align="center" rowspan="1" colspan="1">319 (2.8)</td><td valign="top" align="center" rowspan="1" colspan="1">1573 (3.8)</td><td valign="top" align="center" rowspan="1" colspan="1">318 (2.9)</td><td valign="top" align="center" rowspan="1" colspan="1">0.75 (0.67&#8211;0.85)</td><td valign="top" align="center" rowspan="1" colspan="1">0.84 (0.74&#8211;0.94)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Intensity of palliative care, d, mean &#177; SD</td><td valign="top" align="center" rowspan="1" colspan="1">14.7 (20.0)</td><td valign="top" align="center" rowspan="1" colspan="1">14.7 (20.0)</td><td valign="top" align="center" rowspan="1" colspan="1">14.3 (20.7)</td><td valign="top" align="center" rowspan="1" colspan="1">17.4 (21.1)</td><td valign="top" align="center" rowspan="1" colspan="1">14.3 (20.8)</td><td valign="top" align="center" rowspan="1" colspan="1">0.79 (0.75&#8211;0.84)</td><td valign="top" align="center" rowspan="1" colspan="1">0.84 (0.80&#8211;0.89)</td></tr></tbody></table><table-wrap-foot><fn id="tfn21-196e547"><p>Note: CI = confidence interval, RR = relative risk, SD = standard deviation.</p></fn><fn id="tfn11-196e547"><label>*</label><p>Covariates in modified Poisson regression models were year at index, sex, rurality, income quintile, age and labour force marginalization quintile, immigrant status, Charlson Comorbidity Index, asthma, HIV, hepatitis C, infective endocarditis, cancer, congestive heart failure, chronic obstructive pulmonary disease, renal disease, osteoarthritis, and history of harms from non-opioid substances (stimulants, benzodiazepines, alcohol). Interaction terms were used to evaluate whether associations between OUD and each variable differed by cancer status.</p></fn><fn id="tfn12-196e547"><label>&#8224;</label><p>Unless indicated otherwise.</p></fn><fn id="tfn13-196e547"><label>&#8225;</label><p>Decedents with OUD were matched to decedents without OUD group on age (&#177; 2 yr).</p></fn><fn id="tfn14-196e547"><label>&#167;</label><p>Palliative home care is publicly funded home-based palliative care services including case coordinator, nurse, personal support worker, occupational therapy, physiotherapy, and equipment. It does not include physician visits.</p></fn></table-wrap-foot></table-wrap><p>When we looked back 1 year from death for the people who received palliative care (<italic toggle="yes">n</italic> = 489 135), we found that palliative care was started earlier for people with OUD than for those without OUD (mean 174.9 d [SD 129.1] v. 141.3 d [SD 125.4] before death, standardized difference 0.26). People with OUD were less likely to have palliative care started within the last 90 days of their lives (34.2% v. 46.4%; standardized difference 0.25) (<xref rid="t4-196e547" ref-type="table">Table 4</xref>).</p><table-wrap position="float" id="t4-196e547" orientation="portrait"><label>Table 4:</label><caption><p>Timing of palliative care among all decedents who received palliative care within 365 days of death, comparing those with a history of opioid use disorder (OUD) to those without OUD</p></caption><table frame="box" rules="rows"><thead><tr><th valign="bottom" rowspan="2" align="left" colspan="1">Characteristic</th><th colspan="8" valign="bottom" align="center" rowspan="1">No. (%) of decedents<xref rid="tfn15-196e547" ref-type="table-fn">*</xref></th><th valign="bottom" rowspan="2" align="center" colspan="1">Std Diff<xref rid="tfn17-196e547" ref-type="table-fn">&#8225;</xref></th></tr><tr><th valign="bottom" align="center" rowspan="1" colspan="1">Total<break/>
<italic toggle="yes">n</italic> = 521 452</th><th valign="bottom" align="center" rowspan="1" colspan="1">No OUD, total<break/>
<italic toggle="yes">n</italic> = 515 220</th><th valign="bottom" align="center" rowspan="1" colspan="1">OUD, total<break/>
<italic toggle="yes">n</italic> = 6232</th><th valign="bottom" align="center" rowspan="1" colspan="1">OUD, hospital admissions or ED visits only<break/>
<italic toggle="yes">n</italic> = 2370</th><th valign="bottom" align="center" rowspan="1" colspan="1">OUD, OAT only<break/>
<italic toggle="yes">n</italic> = 2400</th><th valign="bottom" align="center" rowspan="1" colspan="1">OUD, hospital admissions or ED visits and OAT<break/>
<italic toggle="yes">n</italic> = 1462</th><th valign="bottom" align="center" rowspan="1" colspan="1">No OUD, age- matched<xref rid="tfn16-196e547" ref-type="table-fn">&#8224;</xref><break/>
<italic toggle="yes">n</italic> = 25 353</th><th valign="bottom" align="center" rowspan="1" colspan="1">OUD, age- matched<xref rid="tfn16-196e547" ref-type="table-fn">&#8224;</xref><break/>
<italic toggle="yes">n</italic> = 6186</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Palliative care started within last 90 d before death</td><td valign="top" align="center" rowspan="1" colspan="1">258 612 (49.6)</td><td valign="top" align="center" rowspan="1" colspan="1">256 478 (49.8)</td><td valign="top" align="center" rowspan="1" colspan="1">2134 (34.2)</td><td valign="top" align="center" rowspan="1" colspan="1">576 (24.3)</td><td valign="top" align="center" rowspan="1" colspan="1">1183 (49.3)</td><td valign="top" align="center" rowspan="1" colspan="1">375 (25.6)</td><td valign="top" align="center" rowspan="1" colspan="1">11 768 (46.4)</td><td valign="top" align="center" rowspan="1" colspan="1">2114 (34.2)</td><td valign="top" align="center" rowspan="1" colspan="1">0.25</td></tr><tr><td colspan="10" valign="top" align="left" rowspan="1">Setting for palliative care, if started within last 90 d before death</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Acute care</td><td valign="top" align="center" rowspan="1" colspan="1">169 992 (32.6)</td><td valign="top" align="center" rowspan="1" colspan="1">168 097 (65.5)</td><td valign="top" align="center" rowspan="1" colspan="1">1895 (88.8)</td><td valign="top" align="center" rowspan="1" colspan="1">468 (81.3)</td><td valign="top" align="center" rowspan="1" colspan="1">1067 (90.2)</td><td valign="top" align="center" rowspan="1" colspan="1">360 (96.0)</td><td valign="top" align="center" rowspan="1" colspan="1">9087 (77.2)</td><td valign="top" align="center" rowspan="1" colspan="1">1876 (88.7)</td><td valign="top" align="center" rowspan="1" colspan="1">0.31</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Clinic</td><td valign="top" align="center" rowspan="1" colspan="1">19 898 (3.8)</td><td valign="top" align="center" rowspan="1" colspan="1">19 822 (7.7)</td><td valign="top" align="center" rowspan="1" colspan="1">76 (3.6)</td><td valign="top" align="center" rowspan="1" colspan="1">28 (4.9)</td><td valign="top" align="center" rowspan="1" colspan="1">38&#8211;42<xref rid="tfn18-196e547" ref-type="table-fn">&#167;</xref></td><td valign="top" align="center" rowspan="1" colspan="1">3&#8211;7<xref rid="tfn18-196e547" ref-type="table-fn">&#167;</xref></td><td valign="top" align="center" rowspan="1" colspan="1">885 (7.5)</td><td valign="top" align="center" rowspan="1" colspan="1">76 (3.6)</td><td valign="top" align="center" rowspan="1" colspan="1">0.17</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Home</td><td valign="top" align="center" rowspan="1" colspan="1">39 191 (7.5)</td><td valign="top" align="center" rowspan="1" colspan="1">39 054 (15.2)</td><td valign="top" align="center" rowspan="1" colspan="1">137 (6.4)</td><td valign="top" align="center" rowspan="1" colspan="1">57 (9.9)</td><td valign="top" align="center" rowspan="1" colspan="1">73 (6.2)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (1.9)</td><td valign="top" align="center" rowspan="1" colspan="1">1490 (12.7)</td><td valign="top" align="center" rowspan="1" colspan="1">136 (6.4)</td><td valign="top" align="center" rowspan="1" colspan="1">0.21</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Long-term care</td><td valign="top" align="center" rowspan="1" colspan="1">29 531 (5.7)</td><td valign="top" align="center" rowspan="1" colspan="1">29 505 (11.5)</td><td valign="top" align="center" rowspan="1" colspan="1">26 (1.2)</td><td valign="top" align="center" rowspan="1" colspan="1">23 (4.0)</td><td valign="top" align="center" rowspan="1" colspan="1">1&#8211;5<xref rid="tfn18-196e547" ref-type="table-fn">&#167;</xref></td><td valign="top" align="center" rowspan="1" colspan="1">1&#8211;5<xref rid="tfn18-196e547" ref-type="table-fn">&#167;</xref></td><td valign="top" align="center" rowspan="1" colspan="1">306 (2.6)</td><td valign="top" align="center" rowspan="1" colspan="1">26 (1.2)</td><td valign="top" align="center" rowspan="1" colspan="1">0.1</td></tr><tr><td colspan="10" valign="top" align="left" rowspan="1">Setting for palliative care, if started before 91&#8211;365 d before death</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Acute care</td><td valign="top" align="center" rowspan="1" colspan="1">129 839 (24.9)</td><td valign="top" align="center" rowspan="1" colspan="1">126 740 (49.0)</td><td valign="top" align="center" rowspan="1" colspan="1">3099 (75.6)</td><td valign="top" align="center" rowspan="1" colspan="1">1259 (70.2)</td><td valign="top" align="center" rowspan="1" colspan="1">874 (71.8)</td><td valign="top" align="center" rowspan="1" colspan="1">966 (88.9)</td><td valign="top" align="center" rowspan="1" colspan="1">7771 (57.2)</td><td valign="top" align="center" rowspan="1" colspan="1">3074 (75.5)</td><td valign="top" align="center" rowspan="1" colspan="1">0.39</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Clinic</td><td valign="top" align="center" rowspan="1" colspan="1">27 071 (5.2)</td><td valign="top" align="center" rowspan="1" colspan="1">26 768 (10.3)</td><td valign="top" align="center" rowspan="1" colspan="1">303 (7.4)</td><td valign="top" align="center" rowspan="1" colspan="1">134 (7.5)</td><td valign="top" align="center" rowspan="1" colspan="1">128 (10.5)</td><td valign="top" align="center" rowspan="1" colspan="1">41 (3.8)</td><td valign="top" align="center" rowspan="1" colspan="1">2093 (15.4)</td><td valign="top" align="center" rowspan="1" colspan="1">303 (7.4)</td><td valign="top" align="center" rowspan="1" colspan="1">0.25</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Home</td><td valign="top" align="center" rowspan="1" colspan="1">81 917 (15.7)</td><td valign="top" align="center" rowspan="1" colspan="1">81 310 (31.4)</td><td valign="top" align="center" rowspan="1" colspan="1">607 (14.8)</td><td valign="top" align="center" rowspan="1" colspan="1">332 (18.5)</td><td valign="top" align="center" rowspan="1" colspan="1">201 (16.5)</td><td valign="top" align="center" rowspan="1" colspan="1">74 (6.8)</td><td valign="top" align="center" rowspan="1" colspan="1">3320 (24.4)</td><td valign="top" align="center" rowspan="1" colspan="1">607 (14.9)</td><td valign="top" align="center" rowspan="1" colspan="1">0.24</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Long-term care</td><td valign="top" align="center" rowspan="1" colspan="1">24 013 (4.6)</td><td valign="top" align="center" rowspan="1" colspan="1">23 924 (9.2)</td><td valign="top" align="center" rowspan="1" colspan="1">89 (2.2)</td><td valign="top" align="center" rowspan="1" colspan="1">69 (3.8)</td><td valign="top" align="center" rowspan="1" colspan="1">14 (1.2)</td><td valign="top" align="center" rowspan="1" colspan="1">6 (0.6)</td><td valign="top" align="center" rowspan="1" colspan="1">401 (3.0)</td><td valign="top" align="center" rowspan="1" colspan="1">88 (2.2)</td><td valign="top" align="center" rowspan="1" colspan="1">0.05</td></tr><tr><td colspan="10" valign="top" align="left" rowspan="1">Timing of starting palliative care (0&#8211;365 d before death), d, mean &#177; SD</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Overall</td><td valign="top" align="center" rowspan="1" colspan="1">134.9 &#177; 126.1</td><td valign="top" align="center" rowspan="1" colspan="1">134.4 &#177; 126.0</td><td valign="top" align="center" rowspan="1" colspan="1">174.6 &#177; 129.1</td><td valign="top" align="center" rowspan="1" colspan="1">201.6 &#177; 124.1</td><td valign="top" align="center" rowspan="1" colspan="1">135.9 &#177; 128.1</td><td valign="top" align="center" rowspan="1" colspan="1">194.3 &#177; 123.0</td><td valign="top" align="center" rowspan="1" colspan="1">141.3 &#177; 125.4</td><td valign="top" align="center" rowspan="1" colspan="1">174.9 &#177; 129.1</td><td valign="top" align="center" rowspan="1" colspan="1">0.26</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Acute care</td><td valign="top" align="center" rowspan="1" colspan="1">188.6 &#177; 129.1</td><td valign="top" align="center" rowspan="1" colspan="1">188.3 &#177; 129.1</td><td valign="top" align="center" rowspan="1" colspan="1">239.6 &#177; 125.0</td><td valign="top" align="center" rowspan="1" colspan="1">252.8 &#177; 118.9</td><td valign="top" align="center" rowspan="1" colspan="1">212.2 &#177; 133.1</td><td valign="top" align="center" rowspan="1" colspan="1">268.8 &#177; 108.8</td><td valign="top" align="center" rowspan="1" colspan="1">194.1 &#177; 128.8</td><td valign="top" align="center" rowspan="1" colspan="1">239.8 &#177; 124.8</td><td valign="top" align="center" rowspan="1" colspan="1">0.36</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Clinic</td><td valign="top" align="center" rowspan="1" colspan="1">112.9 &#177; 116.1</td><td valign="top" align="center" rowspan="1" colspan="1">112.1 &#177; 115.8</td><td valign="top" align="center" rowspan="1" colspan="1">160.1 &#177; 126.1</td><td valign="top" align="center" rowspan="1" colspan="1">186.9 &#177; 121.7</td><td valign="top" align="center" rowspan="1" colspan="1">117.5 &#177; 120.7</td><td valign="top" align="center" rowspan="1" colspan="1">187.6 &#177; 122.2</td><td valign="top" align="center" rowspan="1" colspan="1">118.3 &#177; 118.1</td><td valign="top" align="center" rowspan="1" colspan="1">160.3 &#177; 126.1</td><td valign="top" align="center" rowspan="1" colspan="1">0.34</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Home</td><td valign="top" align="center" rowspan="1" colspan="1">151.7 &#177; 125.5</td><td valign="top" align="center" rowspan="1" colspan="1">151.2 &#177; 125.3</td><td valign="top" align="center" rowspan="1" colspan="1">223.2 &#177; 121.4</td><td valign="top" align="center" rowspan="1" colspan="1">229.4 &#177; 119.4</td><td valign="top" align="center" rowspan="1" colspan="1">210.8 &#177; 125.0</td><td valign="top" align="center" rowspan="1" colspan="1">246.2 &#177; 111.7</td><td valign="top" align="center" rowspan="1" colspan="1">183.7 &#177; 119.8</td><td valign="top" align="center" rowspan="1" colspan="1">223.2 &#177; 121.4</td><td valign="top" align="center" rowspan="1" colspan="1">0.33</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Long-term care</td><td valign="top" align="center" rowspan="1" colspan="1">121.1 &#177; 134.8</td><td valign="top" align="center" rowspan="1" colspan="1">120.9 &#177; 134.8</td><td valign="top" align="center" rowspan="1" colspan="1">221.5 &#177; 130.7</td><td valign="top" align="center" rowspan="1" colspan="1">212.7 &#177; 132.8</td><td valign="top" align="center" rowspan="1" colspan="1">265.3 &#177; 99.9</td><td valign="top" align="center" rowspan="1" colspan="1">239.9 &#177; 153.1</td><td valign="top" align="center" rowspan="1" colspan="1">150.6 &#177; 136.7</td><td valign="top" align="center" rowspan="1" colspan="1">220.8 &#177; 131.0</td><td valign="top" align="center" rowspan="1" colspan="1">0.52</td></tr></tbody></table><table-wrap-foot><fn id="tfn22-196e547"><p>Note: ED = emergency department, OAT = opioid agonist treatment, SD = standard deviation, Std Diff = standardized difference.</p></fn><fn id="tfn15-196e547"><label>*</label><p>Unless indicated otherwise. We identified a total of 521 452 decedents who received palliative care within 365 days of death.</p></fn><fn id="tfn16-196e547"><label>&#8224;</label><p>Decedents with OUD were matched to decedents without OUD group on age (&#177; 2 yr).</p></fn><fn id="tfn17-196e547"><label>&#8225;</label><p>Compares age-matched decedents with and without OUD.</p></fn><fn id="tfn18-196e547"><label>&#167;</label><p>Ranges presented to prevent back-calculation of small cell counts (&#8804; 5).</p></fn></table-wrap-foot></table-wrap></sec><sec><title>Secondary analyses</title><p>Before the COVID-19 pandemic (July 1, 2015, to Dec. 31, 2019), we identified a total of 480 368 decedents. Of these decedents, 6940 (1.4%) had OUD. Among the decedents with OUD, 3369 (48.5%) received palliative care in the last 90 days of life, whereas, among 473 428 decedents without OUD, 342 856 (72.4%) received palliative care in the last 90 days of life for an absolute difference of 23.9%. The relative risk of receiving palliative care was 0.67 (95% CI 0.65&#8211;0.68), indicating a 33% lower risk of receiving palliative care for people with OUD compared with those without OUD.</p><p>During the COVID-19 pandemic (Jan. 1, 2020, to Dec. 31, 2021), we identified a total of 199 472 decedents. Of these decedents, 4260 (2.1%) had OUD. Among the decedents with OUD, 1694 (39.8%) received palliative care in the last 90 days of life, whereas, among 195 212 decedents without OUD, 141 216 (72.3%) received palliative care in the last 90 days of life for an absolute difference of 32.6%. The relative risk of receiving palliative care was 0.55 (95% CI 0.53&#8211;0.57), indicating a 45% lower risk of receiving palliative care for people with OUD compared with those without OUD.</p><p>Between July 1, 2015, and Dec. 31, 2018, we identified 323 727 people who did not die suddenly, of whom 2732 (0.84%) had a history of OUD. With the exclusion of sudden deaths, we found that people with and without OUD had similar risk of receiving any palliative care at the end of their lives (adjusted RR 0.99, 95% CI 0.96&#8211;1.01) and of receiving palliative care in long-term care facilities (adjusted RR 0.98, 95% CI 0.83&#8211;1.15). People with OUD were, however, still less likely to receive palliative care in clinics (adjusted RR 0.79, 95% CI 0.74&#8211;0.85) and at home (adjusted RR 0.75, 95% CI 0.70&#8211;0.81). Palliative care intensity at the end of life also remained lower for people with OUD than for those without OUD (IRR 0.90, 95% CI 0.83&#8211;0.98). When we looked back 1 year from death for the people who received palliative care (<italic toggle="yes">n</italic> = 255 233), those with OUD had palliative care started, on average, 35.8 days earlier than those without OUD (mean 178.0 d v. 142.3 d, standardized difference 0.28). Appendix 8, available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="www.cmaj.ca/lookup/doi/10.1503/cmaj.231419/tab-related-content" ext-link-type="uri">www.cmaj.ca/lookup/doi/10.1503/cmaj.231419/tab-related-content</ext-link>, presents this subcohort&#8217;s demographics and medical histories, including the top 10 causes of death, and models that evaluated the associations between OUD and palliative care receipt, setting, and intensity.</p></sec></sec><sec sec-type="discussion"><title>Interpretation</title><p>In this population-based study, we comprehensively described the characteristics of people with OUD at the end of their lives and evaluated the association between OUD and receipt of palliative care. Compared with people without OUD, we found that people with OUD died at a younger age and were more likely to have neighbourhood indices associated with high marginalization. Although palliative care was started, on average, 33.6 days earlier for people with OUD in the last year of life than those without OUD, we found that people with OUD were 16% less likely to receive any palliative care at the end of life, after matching for age and adjusting for potentially confounding demographic and clinical variables. This finding is most likely owing to the high proportion of people with OUD who suddenly die from drug poisonings;<xref rid="b40-196e547" ref-type="bibr">40</xref> we found that people with and without OUD had similar likelihood of receiving palliative care after we excluded sudden deaths from our cohort. Regardless of cause of death, we identified that people with OUD were less likely to receive palliative care in their homes and in clinics. These findings suggest that people with OUD are likely not receiving palliative care that is meeting all their end-of-life needs, especially considering their complex health and social profiles. The COVID-19 pandemic further exacerbated inequities in palliative care between people with and without OUD.</p><p>Opioid use disorder is a life-limiting condition that results in considerable functional impairment and distress. Use of opioids from the unregulated drug supply is associated with serious medical issues that require emergent attention, which may explain why people with OUD are accessing palliative care earlier and more often in acute care hospitals. Consistent with existing evidence, our study found that the most common indications for people with OUD to receive palliative care were cancer, liver cirrhosis, sepsis, and pneumonia.<xref rid="b7-196e547" ref-type="bibr">7</xref>,<xref rid="b40-196e547" ref-type="bibr">40</xref>&#8211;<xref rid="b43-196e547" ref-type="bibr">43</xref> Although sepsis and pneumonia are acute conditions, patients with poor prognoses, comorbid life-limiting conditions, or history of multiple hospital admissions can benefit from palliative care to assist them with symptom management and goals-of-care discussions.<xref rid="b44-196e547" ref-type="bibr">44</xref>,<xref rid="b45-196e547" ref-type="bibr">45</xref> We identified that people with OUD were 17%&#8211;38% less likely to receive palliative care in clinics, in their homes and in long-term care facilities. Stigma toward people who have substance use disorders can contribute to late referrals and missed opportunities to receive palliative care in the community.<xref rid="b46-196e547" ref-type="bibr">46</xref></p><p>Our study demonstrated that the known socioeconomic inequities experienced by people living with OUD persist until the end of their lives.<xref rid="b13-196e547" ref-type="bibr">13</xref> People with OUD are more likely to experience structural vulnerability than the general population, even with publicly funded social assistance programs in Canada.<xref rid="b47-196e547" ref-type="bibr">47</xref> As in other studies, we found that people with OUD were more likely to have worse mental health and higher chronic morbidity.<xref rid="b7-196e547" ref-type="bibr">7</xref>,<xref rid="b41-196e547" ref-type="bibr">41</xref> All of these factors likely contributed to our findings that people with OUD died at a young age for all causes of death, not just drug toxicity.</p><p>In our analysis, we matched people with and without OUD on age and controlled for factors like income and comorbid substance use to focus on the association between OUD and palliative care. The reality, however, is that palliative care for people with OUD needs to be viewed through the lens of intersectionality rather than isolating for a particular relationship. Although most people in Canada state that they want to die at home,<xref rid="b48-196e547" ref-type="bibr">48</xref> those with OUD who have limited social supports, limited finances, and unstable housing will experience challenges with accessing palliative care in the community. If people have serious mental illness or are actively using substances, their access to home care services can be limited because their homes may be deemed unsafe.<xref rid="b49-196e547" ref-type="bibr">49</xref> Further, people in the community who are focused on surviving and meeting their basic needs report that they do not prioritize advance care planning and accessing palliative care until they are admitted to acute care.<xref rid="b49-196e547" ref-type="bibr">49</xref> To help people with OUD overcome these barriers, health care providers, particularly those in acute care hospitals, should consider assessing for structural vulnerability using tools like the Structural Vulnerability Assessment Tool<xref rid="b50-196e547" ref-type="bibr">50</xref> and prioritize addressing inequities in social determinants of health as much as symptom management. Health care providers should receive training in palliative care and addiction medicine to provide equitable end-of-life care for people with OUD and other substance use disorders.<xref rid="b51-196e547" ref-type="bibr">51</xref></p><sec><title>Limitations</title><p>We used Ontario health administrative databases to identify those with OUD based on previous health care use and use of opioid agonist treatment. This definition may underestimate the population at risk, as some people with substance use disorders avoid receiving care because of barriers like stigma experienced in health care.<xref rid="b52-196e547" ref-type="bibr">52</xref> Thus, generalizability of our findings is limited to those who access health care at the end of their lives. The ICES databases do not have data about gender and have only neighbourhood-level marginalization indices rather than individual-level data about housing status, race, and income. Previous studies demonstrated that OUD is disproportionally concentrated among structurally vulnerable groups, including people living in poverty and homelessness, who often also experience racism and trauma.<xref rid="b49-196e547" ref-type="bibr">49</xref> Gender disparities also exist, with men more likely to die from opioid poisoning.<xref rid="b53-196e547" ref-type="bibr">53</xref> Given these important limitations, we are conducting a qualitative study to analyze the impact of these factors on palliative care for people with OUD.</p></sec></sec><sec><title>Conclusion</title><p>We identified important differences in palliative care provided at the end of life between people with and without OUD. People with OUD were less likely to receive palliative care despite accessing palliative care earlier, which may reflect their end-of-life illness trajectories and underlying structural vulnerability that may prompt them to receive palliative care primarily in acute care. Health care providers should receive training in palliative care and addiction medicine to support people with OUD. Future work is needed to evaluate the impact of palliative care on opioid prescribing, health care use, and place of death for people with OUD, and to explore the end-of-life experiences of people with OUD and their caregivers.</p></sec></body><back><ack><title>Acknowledgements</title><p>The authors thank the Pan-Canadian Palliative Care Research Collaborative, Dr. Leonie Herx (Canadian Society of Palliative Care Physicians), and Ms. Shelly Cory (Canadian Virtual Hospice) for their valuable contributions to this project. They also thank the Toronto Community Health Profiles Partnership for providing access to the Ontario Marginalization Index.</p></ack><fn-group><fn id="fn1-196e547" fn-type="COI-statement"><p><bold>Competing interests:</bold> Jenny Lau reports honoraria from the University of Toronto and travel funding from the Canadian Institutes of Health Research and Health Canada. She is a member of the Global Institute of Psychosocial, Palliative and End-of-Life Care Operations Committee and medical director of the Harold and Shirley Lederman Palliative Care Centre. Tara Gomes reports research funding from the Ontario Ministry of Health, the Ontario College of Pharmacists, and the Canadian Agency for Drugs and Technologies in Health; consulting fees from the Auditor General of British Columbia; payment for expert testimony from the Office of the Chief Coroner of Ontario; and travel support from Indigenous Services Canada. She is a Tier 2 Canada Research Chair in Drug Policy Research &amp; Evaluation. Sarina Isenberg reports travel funding from the American Association of Hospice Palliative Medicine. She is director of the St. Joseph&#8217;s Villa Foundation Board of Directors and a member of the Temple Anshe Sholom Succession Planning Committee. No other competing interests were declared.</p></fn><fn id="fn2-196e547"><p>This article has been peer reviewed.</p></fn><fn id="fn3-196e547"><p><bold>Contributors:</bold> Jenny Lau, Mary Scott, Karl Everett, Tara Gomes, Peter Tanuseputro, and Sarina Isenberg contributed to the conception and design of the work. Karl Everett contributed to the acquisition of the data. Jenny Lau, Mary Scott, Karl Everett, Tara Gomes, Peter Tanuseputro, and Sarina Isenberg contributed to data analysis. All of the authors contributed to interpretation of the data. Jenny Lau, Mary Scott, Rebecca Bagnarol, and Sarina Isenberg drafted the manuscript. All authors revised the manuscript critically for important intellectual content, gave final approval of the version to be published, and agreed to be accountable for all aspects of the work.</p></fn><fn id="fn4-196e547"><p><bold>Funding:</bold> This study was supported by ICES, which is funded by a grant from the Government of Ontario. This work was also supported by the Ontario Health Data Platform (OHDP), a Province of Ontario initiative to support Ontario&#8217;s ongoing response to COVID-19 and its related impacts. This study also received funding from the Canadian Institutes of Health Research (RN467572 &#8212; 471128) and Health Canada&#8217;s Health Care Policy and Strategies Program.</p></fn><fn id="fn5-196e547"><p><bold>Data sharing:</bold> The data set from this study is held securely in coded form at ICES. While legal data sharing agreements between ICES and data providers (e.g., health care organizations and government) prohibit ICES from making the data set publicly available, access may be granted to those who meet prespecified criteria for confidential access, available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="www.ices.on.ca/DAS" ext-link-type="uri">www.ices.on.ca/DAS</ext-link> (email: <email>das@ices.on.ca</email>). The full data set creation plan and underlying analytic code are available from the authors upon request, understanding that the computer programs may rely upon coding templates or macros that are unique to ICES and are therefore either inaccessible or may require modification.</p></fn><fn id="fn6-196e547"><p><bold>Disclaimer:</bold> This study was supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health (MOH) and Ministry of Long-Term Care (MLTC). The opinions, results, and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOH and MLTC is intended or should be inferred. Parts of this material are based on data or information compiled and provided by the Canadian Institutes of Health Research, Ontario Health, Ontario Ministry of Health, and Immigration, Refugees and Citizenship Permanent Resident Canada current to September 2020. The authors thank IQVIA Solutions Canada Inc. for use of their Drug Information File. This document uses data adapted from the Statistics Canada Postal Code<sup>OM</sup> Conversion File, which is based on data licensed from Canada Post Corporation, and/or data adapted from the Ontario Ministry of Health Postal Code Conversion File, which contains data copied under license from Canada Post Corporation and Statistics Canada. The analyses, conclusions, opinions, and statements expressed herein are solely those of the authors and do not reflect those of the funding or data sources; no endorsement is intended or should be inferred. No endorsement by the Ontario Health Data Platform, its partners, or the Province of Ontario is intended or should be inferred.</p></fn></fn-group><ref-list><title>References</title><ref id="b1-196e547"><label>1</label><mixed-citation publication-type="book"><source>Report of the International Narcotics Control Board for 2019</source>. <publisher-loc>Vienna (Austria)</publisher-loc>: <publisher-name>International Narcotics Control Board, United Nations</publisher-name>; <year>2020</year>:<fpage>1</fpage>&#8211;<lpage>146</lpage>.</mixed-citation></ref><ref id="b2-196e547"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pearce</surname><given-names>LA</given-names></name><name name-style="western"><surname>Min</surname><given-names>JE</given-names></name><name name-style="western"><surname>Piske</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study</article-title>. <source>BMJ</source><year>2020</year>;<volume>368</volume>:<fpage>m772</fpage>. doi:<pub-id pub-id-type="doi">10.1136/bmj.m772</pub-id>.<pub-id pub-id-type="pmid">32234712</pub-id><pub-id pub-id-type="pmcid">PMC7190018</pub-id></mixed-citation></ref><ref id="b3-196e547"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Warner-Smith</surname><given-names>M</given-names></name><name name-style="western"><surname>Darke</surname><given-names>S</given-names></name><name name-style="western"><surname>Day</surname><given-names>C</given-names></name></person-group>. <article-title>Morbidity associated with non-fatal heroin overdose</article-title>. <source>Addiction</source><year>2002</year>;<volume>97</volume>:<fpage>963</fpage>&#8211;<lpage>7</lpage>.<pub-id pub-id-type="pmid">12144598</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1046/j.1360-0443.2002.00132.x</pub-id></mixed-citation></ref><ref id="b4-196e547"><label>4</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Zibbell</surname><given-names>J</given-names></name><name name-style="western"><surname>Howard</surname><given-names>J</given-names></name><name name-style="western"><surname>Clarke</surname><given-names>SD</given-names></name><etal/></person-group>. <source>Non-fatal opioid overdose and associated health outcomes: final summary report</source>. <publisher-loc>Washington (DC)</publisher-loc>: <publisher-name>U.S. Department of Health and Human Services</publisher-name>; <year>2019</year>:<fpage>1</fpage>&#8211;<lpage>33</lpage>. <comment>Available: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://aspe.hhs.gov/reports/non-fatal-opioid-overdose-associated-health-outcomes-final-summary-report" ext-link-type="uri">https://aspe.hhs.gov/reports/non-fatal-opioid-overdose-associated-health-outcomes-final-summary-report</ext-link></comment> (<date-in-citation content-type="access-date">accessed 2024 Jan. 24</date-in-citation>).</mixed-citation></ref><ref id="b5-196e547"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Strang</surname><given-names>J</given-names></name><name name-style="western"><surname>Volkow</surname><given-names>ND</given-names></name><name name-style="western"><surname>Degenhardt</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Opioid use disorder</article-title>. <source>Nat Rev Dis Primers</source><year>2020</year>;<volume>6</volume>:<fpage>3</fpage>.<pub-id pub-id-type="pmid">31919349</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41572-019-0137-5</pub-id></mixed-citation></ref><ref id="b6-196e547"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ebenau</surname><given-names>A</given-names></name><name name-style="western"><surname>Dijkstra</surname><given-names>B</given-names></name><name name-style="western"><surname>Ter Huurne</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Palliative care for patients with substance use disorder and multiple problems: a qualitative study on experiences of healthcare professionals, volunteers and experts-by-experience</article-title>. <source>BMC Palliat Care</source><year>2020</year>;<volume>19</volume>:<fpage>8</fpage>.<pub-id pub-id-type="pmid">31937289</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12904-019-0502-x</pub-id><pub-id pub-id-type="pmcid">PMC6961318</pub-id></mixed-citation></ref><ref id="b7-196e547"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bech</surname><given-names>AB</given-names></name><name name-style="western"><surname>Clausen</surname><given-names>T</given-names></name><name name-style="western"><surname>Waal</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Mortality and causes of death among patients with opioid use disorder receiving opioid agonist treatment: a national register study</article-title>. <source>BMC Health Serv Res</source><year>2019</year>;<volume>19</volume>:<fpage>440</fpage>.<pub-id pub-id-type="pmid">31266495</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12913-019-4282-z</pub-id><pub-id pub-id-type="pmcid">PMC6604272</pub-id></mixed-citation></ref><ref id="b8-196e547"><label>8</label><mixed-citation publication-type="book"><source>Palliative care</source>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>. <comment>Available: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.who.int/health-topics/palliative-care" ext-link-type="uri">https://www.who.int/health-topics/palliative-care</ext-link></comment> (<date-in-citation content-type="access-date">accessed 2024 Jan. 24</date-in-citation>).</mixed-citation></ref><ref id="b9-196e547"><label>9</label><mixed-citation publication-type="book"><source>Access to palliative care in Canada</source>. <publisher-loc>Ottawa</publisher-loc>: <publisher-name>Canadian Institute for Health Information</publisher-name>; <year>2018</year>:<fpage>1</fpage>&#8211;<lpage>67</lpage>.</mixed-citation></ref><ref id="b10-196e547"><label>10</label><mixed-citation publication-type="book"><source>Get coverage for prescription drugs.</source><publisher-loc>Toronto</publisher-loc>: <publisher-name>Ontario Ministry of Health</publisher-name>; <year>2024</year>. <comment>Available: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ontario.ca/page/get-coverage-prescription-drugs" ext-link-type="uri">https://www.ontario.ca/page/get-coverage-prescription-drugs</ext-link></comment> (<date-in-citation content-type="access-date">accessed 2024 Mar. 25</date-in-citation>).</mixed-citation></ref><ref id="b11-196e547"><label>11</label><mixed-citation publication-type="book"><source>International Statistical Classification of Diseases and Related Health Problems</source>. 10th Revision. <publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2019</year>. <comment>Available: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://icd.who.int/browse10/2019/en" ext-link-type="uri">https://icd.who.int/browse10/2019/en</ext-link></comment> (<date-in-citation content-type="access-date">accessed 2024 Jan. 24</date-in-citation>).</mixed-citation></ref><ref id="b12-196e547"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Degenhardt</surname><given-names>L</given-names></name><name name-style="western"><surname>Bruno</surname><given-names>R</given-names></name><name name-style="western"><surname>Lintzeris</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Agreement between definitions of pharmaceutical opioid use disorders and dependence in people taking opioids for chronic non-cancer pain (POINT): a cohort study</article-title>. <source>Lancet Psychiatry</source><year>2015</year>;<volume>2</volume>:<fpage>314</fpage>&#8211;<lpage>22</lpage>.<pub-id pub-id-type="pmid">26360084</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2215-0366(15)00005-X</pub-id></mixed-citation></ref><ref id="b13-196e547"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Piske</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>H</given-names></name><name name-style="western"><surname>Min</surname><given-names>JE</given-names></name><etal/></person-group>. <article-title>The cascade of care for opioid use disorder: a retrospective study in British Columbia, Canada</article-title>. <source>Addiction</source><year>2020</year>;<volume>115</volume>:<fpage>1482</fpage>&#8211;<lpage>93</lpage>.<pub-id pub-id-type="pmid">31899565</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/add.14947</pub-id></mixed-citation></ref><ref id="b14-196e547"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murray</surname><given-names>SA</given-names></name><name name-style="western"><surname>Kendall</surname><given-names>M</given-names></name><name name-style="western"><surname>Boyd</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Illness trajectories and palliative care</article-title>. <source>BMJ</source><year>2005</year>;<volume>330</volume>:<fpage>1007</fpage>&#8211;<lpage>11</lpage>.<pub-id pub-id-type="pmid">15860828</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.330.7498.1007</pub-id><pub-id pub-id-type="pmcid">PMC557152</pub-id></mixed-citation></ref><ref id="b15-196e547"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gershon</surname><given-names>AS</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C</given-names></name><name name-style="western"><surname>Guan</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Identifying individuals with physcian diagnosed COPD in health administrative databases</article-title>. <source>COPD</source><year>2009</year>;<volume>6</volume>:<fpage>388</fpage>&#8211;<lpage>94</lpage>.<pub-id pub-id-type="pmid">19863368</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15412550903140865</pub-id></mixed-citation></ref><ref id="b16-196e547"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosella</surname><given-names>LC</given-names></name><name name-style="western"><surname>Manuel</surname><given-names>DG</given-names></name><name name-style="western"><surname>Burchill</surname><given-names>C</given-names></name><etal/></person-group>.; <collab>PHIAT-DM team</collab>. <article-title>A population-based risk algorithm for the development of diabetes: development and validation of the Diabetes Population Risk Tool (DPoRT)</article-title>. <source>J Epidemiol Community Health</source><year>2011</year>;<volume>65</volume>:<fpage>613</fpage>&#8211;<lpage>20</lpage>.<pub-id pub-id-type="pmid">20515896</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/jech.2009.102244</pub-id><pub-id pub-id-type="pmcid">PMC3112365</pub-id></mixed-citation></ref><ref id="b17-196e547"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thavorn</surname><given-names>K</given-names></name><name name-style="western"><surname>Maxwell</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Gruneir</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Effect of socio-demographic factors on the association between multimorbidity and healthcare costs: a population-based, retrospective cohort study</article-title>. <source>BMJ Open</source><year>2017</year>;<volume>7</volume>:<fpage>e017264</fpage>. doi:<pub-id pub-id-type="doi">10.1136/bmjopen-2017-017264</pub-id>.<pub-id pub-id-type="pmcid">PMC5640069</pub-id><pub-id pub-id-type="pmid">28988178</pub-id></mixed-citation></ref><ref id="b18-196e547"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Petrosyan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Bai</surname><given-names>YQ</given-names></name><name name-style="western"><surname>Kon&#233; Pefoyo</surname><given-names>AJ</given-names></name><etal/></person-group>. <article-title>The relationship between diabetes care quality and diabetes-related hospitalizations and the modifying role of comorbidity</article-title>. <source>Can J Diabetes</source><year>2017</year>;<volume>41</volume>:<fpage>17</fpage>&#8211;<lpage>25</lpage>.<pub-id pub-id-type="pmid">27789111</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jcjd.2016.06.006</pub-id></mixed-citation></ref><ref id="b19-196e547"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lane</surname><given-names>NE</given-names></name><name name-style="western"><surname>Maxwell</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Gruneir</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Absence of a socioeconomic gradient in older adults&#8217; survival with multiple chronic conditions</article-title>. <source>EBioMedicine</source><year>2015</year>;<volume>2</volume>:<fpage>2094</fpage>&#8211;<lpage>100</lpage>.<pub-id pub-id-type="pmid">26844290</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ebiom.2015.11.018</pub-id><pub-id pub-id-type="pmcid">PMC4703730</pub-id></mixed-citation></ref><ref id="b20-196e547"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mondor</surname><given-names>L</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>D</given-names></name><name name-style="western"><surname>Khan</surname><given-names>AI</given-names></name><etal/></person-group>. <article-title>Income inequalities in multimorbidity prevalence in Ontario, Canada: a decomposition analysis of linked survey and health administrative data</article-title>. <source>Int J Equity Health</source><year>2018</year>;<volume>17</volume>:<fpage>90</fpage>.<pub-id pub-id-type="pmid">29941034</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12939-018-0800-6</pub-id><pub-id pub-id-type="pmcid">PMC6019796</pub-id></mixed-citation></ref><ref id="b21-196e547"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mondor</surname><given-names>L</given-names></name><name name-style="western"><surname>Maxwell</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Bronskill</surname><given-names>SE</given-names></name><etal/></person-group>. <article-title>The relative impact of chronic conditions and multimorbidity on health-related quality of life in Ontario long-stay home care clients</article-title>. <source>Qual Life Res</source><year>2016</year>;<volume>25</volume>:<fpage>2619</fpage>&#8211;<lpage>32</lpage>.<pub-id pub-id-type="pmid">27052421</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11136-016-1281-y</pub-id></mixed-citation></ref><ref id="b22-196e547"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mondor</surname><given-names>L</given-names></name><name name-style="western"><surname>Maxwell</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Hogan</surname><given-names>DB</given-names></name><etal/></person-group>. <article-title>Multimorbidity and healthcare utilization among home care clients with dementia in Ontario, Canada: a retrospective analysis of a population-based cohort</article-title>. <source>PLoS Med</source><year>2017</year>;<volume>14</volume>:<fpage>e1002249</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pmed.1002249</pub-id>.<pub-id pub-id-type="pmid">28267802</pub-id><pub-id pub-id-type="pmcid">PMC5340355</pub-id></mixed-citation></ref><ref id="b23-196e547"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gruneir</surname><given-names>A</given-names></name><name name-style="western"><surname>Bronskill</surname><given-names>SE</given-names></name><name name-style="western"><surname>Maxwell</surname><given-names>CJ</given-names></name><etal/></person-group>. <article-title>The association between multimorbidity and hospitalization is modified by individual demographics and physician continuity of care: a retrospective cohort study</article-title>. <source>BMC Health Serv Res</source><year>2016</year>;<volume>16</volume>:<fpage>154</fpage>.<pub-id pub-id-type="pmid">27122051</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12913-016-1415-5</pub-id><pub-id pub-id-type="pmcid">PMC4848783</pub-id></mixed-citation></ref><ref id="b24-196e547"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pefoyo</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Bronskill</surname><given-names>SE</given-names></name><name name-style="western"><surname>Gruneir</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>The increasing burden and complexity of multimorbidity</article-title>. <source>BMC Public Health</source><year>2015</year>;<volume>15</volume>:<fpage>415</fpage>.<pub-id pub-id-type="pmid">25903064</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12889-015-1733-2</pub-id><pub-id pub-id-type="pmcid">PMC4415224</pub-id></mixed-citation></ref><ref id="b25-196e547"><label>25</label><mixed-citation publication-type="book"><person-group person-group-type="editor"><name name-style="western"><surname>Naylor</surname><given-names>CD</given-names></name><name name-style="western"><surname>Slaughter</surname><given-names>PM</given-names></name></person-group>, eds. <source>Cardiovascular health and services in Ontario: an ICES atlas</source>. <publisher-loc>Toronto</publisher-loc>: <publisher-name>Institute for Clinical Evaluative Sciences</publisher-name>; <year>1999</year>. <comment>Available: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ices.on.ca/Publications/Atlases-and-Reports/1999/Cardiovascular-health-and-services" ext-link-type="uri">https://www.ices.on.ca/Publications/Atlases-and-Reports/1999/Cardiovascular-health-and-services</ext-link></comment> (<date-in-citation content-type="access-date">accessed 2024 Jan. 24</date-in-citation>).</mixed-citation></ref><ref id="b26-196e547"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hux</surname><given-names>JE</given-names></name><name name-style="western"><surname>Ivis</surname><given-names>F</given-names></name><name name-style="western"><surname>Flintoft</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm</article-title>. <source>Diabetes Care</source><year>2002</year>;<volume>25</volume>:<fpage>512</fpage>&#8211;<lpage>6</lpage>.<pub-id pub-id-type="pmid">11874939</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2337/diacare.25.3.512</pub-id></mixed-citation></ref><ref id="b27-196e547"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tu</surname><given-names>K</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>NR</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z-L</given-names></name><etal/></person-group>. <article-title>Accuracy of administrative databases in identifying patients with hypertension</article-title>. <source>Open Med</source><year>2007</year>;<volume>1</volume>:<fpage>e18</fpage>&#8211;<lpage>26</lpage>.<pub-id pub-id-type="pmid">20101286</pub-id><pub-id pub-id-type="pmcid">PMC2801913</pub-id></mixed-citation></ref><ref id="b28-196e547"><label>28</label><mixed-citation publication-type="book"><source>Improving health care data in Ontario: ICES investigative report</source>. <publisher-loc>Toronto</publisher-loc>: <publisher-name>Institute for Clinical Evaluative Sciences</publisher-name>; <year>2005</year>:<fpage>1</fpage>&#8211;<lpage>28</lpage>.</mixed-citation></ref><ref id="b29-196e547"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yeung</surname><given-names>DF</given-names></name><name name-style="western"><surname>Boom</surname><given-names>NK</given-names></name><name name-style="western"><surname>Guo</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Trends in the incidence and outcomes of heart failure in Ontario, Canada: 1997 to 2007</article-title>. <source>CMAJ</source><year>2012</year>;<volume>184</volume>:<fpage>E765</fpage>&#8211;<lpage>73</lpage>.<pub-id pub-id-type="pmid">22908143</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1503/cmaj.111958</pub-id><pub-id pub-id-type="pmcid">PMC3470643</pub-id></mixed-citation></ref><ref id="b30-196e547"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wong</surname><given-names>CY</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>W</given-names></name><name name-style="western"><surname>Aurigemma</surname><given-names>GP</given-names></name><etal/></person-group>. <article-title>Infective endocarditis among persons aged 18&#8211;64 years living with human immunodeficiency virus, hepatitis C infection, or opioid use disorder, United States, 2007&#8211;2017</article-title>. <source>Clin Infect Dis</source><year>2021</year>;<volume>72</volume>:<fpage>1767</fpage>&#8211;<lpage>81</lpage>.<pub-id pub-id-type="pmid">32270861</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/cid/ciaa372</pub-id></mixed-citation></ref><ref id="b31-196e547"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tom</surname><given-names>C</given-names></name><name name-style="western"><surname>Huang</surname><given-names>G</given-names></name><name name-style="western"><surname>Kovalic</surname><given-names>AJ</given-names></name><etal/></person-group>. <article-title>Impact of chronic hepatitis C virus co-infection on outcomes of infective endocarditis in people who inject drugs</article-title>. <source>Diagn Microbiol Infect Dis</source><year>2021</year>;<volume>101</volume>:<fpage>115453</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.diagmicrobio.2021.115453</pub-id>.<pub-id pub-id-type="pmid">34339949</pub-id></mixed-citation></ref><ref id="b32-196e547"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tanuseputro</surname><given-names>P</given-names></name><name name-style="western"><surname>Budhwani</surname><given-names>S</given-names></name><name name-style="western"><surname>Bai</surname><given-names>YQ</given-names></name><etal/></person-group>. <article-title>Palliative care delivery across health sectors: a population-level observational study</article-title>. <source>Palliat Med</source><year>2017</year>;<volume>31</volume>:<fpage>247</fpage>&#8211;<lpage>57</lpage>.<pub-id pub-id-type="pmid">27317412</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0269216316653524</pub-id><pub-id pub-id-type="pmcid">PMC5347353</pub-id></mixed-citation></ref><ref id="b33-196e547"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Austin</surname><given-names>PC</given-names></name></person-group>. <article-title>Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research</article-title>. <source>Commun Stat Simul Comput</source><year>2009</year>;<volume>38</volume>:<fpage>1228</fpage>&#8211;<lpage>34</lpage>.</mixed-citation></ref><ref id="b34-196e547"><label>34</label><mixed-citation publication-type="book"><article-title>Evidence review: Timing of referral to palliative care services</article-title>. <source>NICE Guideline, No. 142</source>. <publisher-loc>London (UK)</publisher-loc>: <publisher-name>National Institute for Health and Care Excellence (NICE)</publisher-name>; <year>2019</year>. <comment>Available: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK558768/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/books/NBK558768/</ext-link></comment> (<date-in-citation content-type="access-date">accessed 2023 Apr. 13</date-in-citation>).<pub-id pub-id-type="pmid">32614554</pub-id></mixed-citation></ref><ref id="b35-196e547"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hofman</surname><given-names>SE</given-names></name><name name-style="western"><surname>Lucke</surname><given-names>JA</given-names></name><name name-style="western"><surname>Heim</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Prediction of 90-day mortality in older patients after discharge from an emergency department: a retrospective follow-up study</article-title>. <source>BMC Emerg Med</source><year>2016</year>;<volume>16</volume>:<fpage>26</fpage>.<pub-id pub-id-type="pmid">27412243</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12873-016-0090-5</pub-id><pub-id pub-id-type="pmcid">PMC4944462</pub-id></mixed-citation></ref><ref id="b36-196e547"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Williams</surname><given-names>N</given-names></name><name name-style="western"><surname>Hermans</surname><given-names>K</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>The interRAI CHESS scale is comparable to the palliative performance scale in predicting 90-day mortality in a palliative home care population</article-title>. <source>BMC Palliat Care</source><year>2022</year>;<volume>21</volume>:<fpage>174</fpage>.<pub-id pub-id-type="pmid">36203180</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12904-022-01059-3</pub-id><pub-id pub-id-type="pmcid">PMC9540725</pub-id></mixed-citation></ref><ref id="b37-196e547"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quinn</surname><given-names>KL</given-names></name><name name-style="western"><surname>Wegier</surname><given-names>P</given-names></name><name name-style="western"><surname>Stukel</surname><given-names>TA</given-names></name><etal/></person-group>. <article-title>Comparison of palliative care delivery in the last year of life between adults with terminal noncancer illness or cancer</article-title>. <source>JAMA Netw Open</source><year>2021</year>;<volume>4</volume>:<fpage>e210677</fpage>. doi:<pub-id pub-id-type="doi">10.1001/jamanetworkopen.2021.0677</pub-id>.<pub-id pub-id-type="pmid">33662135</pub-id><pub-id pub-id-type="pmcid">PMC7933993</pub-id></mixed-citation></ref><ref id="b38-196e547"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zou</surname><given-names>G</given-names></name></person-group>. <article-title>A modified poisson regression approach to prospective studies with binary data</article-title>. <source>Am J Epidemiol</source><year>2004</year>;<volume>159</volume>:<fpage>702</fpage>&#8211;<lpage>6</lpage>.<pub-id pub-id-type="pmid">15033648</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/aje/kwh090</pub-id></mixed-citation></ref><ref id="b39-196e547"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cohen-Mansfield</surname><given-names>J</given-names></name><name name-style="western"><surname>Skornick-Bouchbinder</surname><given-names>M</given-names></name><name name-style="western"><surname>Brill</surname><given-names>S</given-names></name></person-group>. <article-title>Trajectories of end of life: a systematic review</article-title>. <source>J Gerontol B Psychol Sci Soc Sci</source><year>2018</year>;<volume>73</volume>:<fpage>564</fpage>&#8211;<lpage>72</lpage>.<pub-id pub-id-type="pmid">28977651</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/geronb/gbx093</pub-id></mixed-citation></ref><ref id="b40-196e547"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hser</surname><given-names>Y-I</given-names></name><name name-style="western"><surname>Mooney</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Saxon</surname><given-names>AJ</given-names></name><etal/></person-group>. <article-title>High mortality among patients with opioid use disorder in a large healthcare system</article-title>. <source>J Addict Med</source><year>2017</year>;<volume>11</volume>:<fpage>315</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="pmid">28426439</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/ADM.0000000000000312</pub-id><pub-id pub-id-type="pmcid">PMC5930020</pub-id></mixed-citation></ref><ref id="b41-196e547"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Larney</surname><given-names>S</given-names></name><name name-style="western"><surname>Tran</surname><given-names>LT</given-names></name><name name-style="western"><surname>Leung</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>All-cause and cause-specific mortality among people using extramedical opioids: a systematic review and meta-analysis</article-title>. <source>JAMA Psychiatry</source><year>2020</year>;<volume>77</volume>:<fpage>493</fpage>&#8211;<lpage>502</lpage>.<pub-id pub-id-type="pmid">31876906</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamapsychiatry.2019.4170</pub-id><pub-id pub-id-type="pmcid">PMC6990804</pub-id></mixed-citation></ref><ref id="b42-196e547"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Degenhardt</surname><given-names>L</given-names></name><name name-style="western"><surname>Bucello</surname><given-names>C</given-names></name><name name-style="western"><surname>Mathers</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies</article-title>. <source>Addiction</source><year>2011</year>;<volume>106</volume>:<fpage>32</fpage>&#8211;<lpage>51</lpage>.<pub-id pub-id-type="pmid">21054613</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1360-0443.2010.03140.x</pub-id></mixed-citation></ref><ref id="b43-196e547"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qureshi</surname><given-names>AI</given-names></name><name name-style="western"><surname>Suri</surname><given-names>MF</given-names></name><name name-style="western"><surname>Guterman</surname><given-names>LR</given-names></name><etal/></person-group>. <article-title>Cocaine use and the likelihood of nonfatal myocardial infarction and stroke: data from the Third National Health and Nutrition Examination Survey</article-title>. <source>Circulation</source><year>2001</year>;<volume>103</volume>:<fpage>502</fpage>&#8211;<lpage>6</lpage>.<pub-id pub-id-type="pmid">11157713</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/01.cir.103.4.502</pub-id></mixed-citation></ref><ref id="b44-196e547"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taylor</surname><given-names>SP</given-names></name><name name-style="western"><surname>Chou</surname><given-names>SH</given-names></name><name name-style="western"><surname>Sierra</surname><given-names>MF</given-names></name><etal/></person-group>. <article-title>Association between adherence to recommended care and outcomes for adult survivors of sepsis</article-title>. <source>Ann Am Thorac Soc</source><year>2020</year>;<volume>17</volume>:<fpage>89</fpage>&#8211;<lpage>97</lpage>.<pub-id pub-id-type="pmid">31644304</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1513/AnnalsATS.201907-514OC</pub-id><pub-id pub-id-type="pmcid">PMC6944350</pub-id></mixed-citation></ref><ref id="b45-196e547"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Faverio</surname><given-names>P</given-names></name><name name-style="western"><surname>Aliberti</surname><given-names>S</given-names></name><name name-style="western"><surname>Bellelli</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>The management of community-acquired pneumonia in the elderly</article-title>. <source>Eur J Intern Med</source><year>2014</year>;<volume>25</volume>: <fpage>312</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="pmid">24360244</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejim.2013.12.001</pub-id><pub-id pub-id-type="pmcid">PMC4102338</pub-id></mixed-citation></ref><ref id="b46-196e547"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cook</surname><given-names>O</given-names></name><name name-style="western"><surname>Doran</surname><given-names>J</given-names></name><name name-style="western"><surname>Crosbie</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Palliative care needs and models of care for people who use drugs and/or alcohol: a mixed methods systematic review</article-title>. <source>Palliat Med</source><year>2022</year>;<volume>36</volume>:<fpage>292</fpage>&#8211;<lpage>304</lpage>.<pub-id pub-id-type="pmid">35184626</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/02692163211061994</pub-id></mixed-citation></ref><ref id="b47-196e547"><label>47</label><mixed-citation publication-type="book"><source>Rent-geared-to-income priority access</source>. <publisher-loc>Toronto</publisher-loc>: <publisher-name>City of Toronto</publisher-name>. <comment>Available: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.toronto.ca/community-people/employment-social-support/housing-support/rent-geared-to-income-subsidy/rent-geared-to-income-priority-access/" ext-link-type="uri">https://www.toronto.ca/community-people/employment-social-support/housing-support/rent-geared-to-income-subsidy/rent-geared-to-income-priority-access/</ext-link></comment> (<date-in-citation content-type="access-date">accessed 2024 Jan. 24</date-in-citation>).</mixed-citation></ref><ref id="b48-196e547"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Funk</surname><given-names>LM</given-names></name><name name-style="western"><surname>Mackenzie</surname><given-names>CS</given-names></name><name name-style="western"><surname>Cherba</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Where would Canadians prefer to die? Variation by situational severity, support for family obligations, and age in a national study</article-title>. <source>BMC Palliat Care</source><year>2022</year>;<volume>21</volume>:<fpage>139</fpage>.<pub-id pub-id-type="pmid">35909120</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12904-022-01023-1</pub-id><pub-id pub-id-type="pmcid">PMC9340714</pub-id></mixed-citation></ref><ref id="b49-196e547"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stajduhar</surname><given-names>KI</given-names></name><name name-style="western"><surname>Mollison</surname><given-names>A</given-names></name><name name-style="western"><surname>Giesbrecht</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>&#8220;Just too busy living in the moment and surviving&#8221;: barriers to accessing health care for structurally vulnerable populations at end-of-life</article-title>. <source>BMC Palliat Care</source><year>2019</year>;<volume>18</volume>:<fpage>11</fpage>.<pub-id pub-id-type="pmid">30684959</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12904-019-0396-7</pub-id><pub-id pub-id-type="pmcid">PMC6348076</pub-id></mixed-citation></ref><ref id="b50-196e547"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bourgois</surname><given-names>P</given-names></name><name name-style="western"><surname>Holmes</surname><given-names>SM</given-names></name><name name-style="western"><surname>Sue</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Structural vulnerability: operationalizing the concept to address health disparities in clinical care</article-title>. <source>Acad Med</source><year>2017</year>;<volume>92</volume>:<fpage>299</fpage>&#8211;<lpage>307</lpage>.<pub-id pub-id-type="pmid">27415443</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/ACM.0000000000001294</pub-id><pub-id pub-id-type="pmcid">PMC5233668</pub-id></mixed-citation></ref><ref id="b51-196e547"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chua</surname><given-names>IS</given-names></name><name name-style="western"><surname>Fratt</surname><given-names>E</given-names></name><name name-style="western"><surname>Ho</surname><given-names>JJ</given-names></name><etal/></person-group>. <article-title>Primary addiction medicine skills for hospice and palliative medicine physicians: a modified Delphi study</article-title>. <source>J Pain Symptom Manage</source><year>2021</year>;<volume>62</volume>:<fpage>720</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="pmid">33677071</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jpainsymman.2021.02.035</pub-id></mixed-citation></ref><ref id="b52-196e547"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Boekel</surname><given-names>LC</given-names></name><name name-style="western"><surname>Brouwers</surname><given-names>EPM</given-names></name><name name-style="western"><surname>van Weeghel</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review</article-title>. <source>Drug Alcohol Depend</source><year>2013</year>;<volume>131</volume>:<fpage>23</fpage>&#8211;<lpage>35</lpage>.<pub-id pub-id-type="pmid">23490450</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.drugalcdep.2013.02.018</pub-id></mixed-citation></ref><ref id="b53-196e547"><label>53</label><mixed-citation publication-type="book"><source>Opioid- and stimulant-related harms in Canada</source>. <publisher-name>Ottawa Government of Canada</publisher-name>; <comment>modified 2023 Dec. 15. Available: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://health-infobase.canada.ca/substance-related-harms/opioids-stimulants/" ext-link-type="uri">https://health-infobase.canada.ca/substance-related-harms/opioids-stimulants/</ext-link></comment> (<date-in-citation content-type="access-date">accessed 2024 Jan. 24</date-in-citation>).</mixed-citation></ref></ref-list></back></article></pmc-articleset>